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CHAPTER 1:  GENERAL INTRODUCTION 
 
Statement of the Problem 
 Campylobacter spp. have been recognized as an important cause of sheep 
abortion for decades,
1
 and, historically, the most common isolates have been C. fetus 
subsp. fetus, C. jejuni, and C. coli, with decreasing frequency, respectively.
1-5
  Epizootics 
of abortion often occur within affected flocks with up to 50% of the flock aborting,
1
 and, 
during these epizootics, two or even all three species of Campylobacter have been 
recovered from the same flock.
1
  Additionally, abortion-associated isolates of both C. 
fetus subsp. fetus and C. jejuni have traditionally shown antigenic and genetic 
heterogeneity across flocks and across lambing seasons.
3,6-8
 
 Two recent analyses
9,10
 of ovine abortion-associated Campylobacter isolates have 
revealed that C. jejuni has replaced C. fetus subsp. fetus as the predominant species 
isolated, and, in one of these analyses,
10
 which surveyed isolates from multiple states and 
across multiple lambing seasons, 93% of the C. jejuni isolates were of a single genetic 
clone (named clone SA for Sheep Abortion) and 100% were resistant to tetracycline.  The 
emergence of a single clone of tetracycline-resistant C. jejuni associated with the 
preponderance of abortions across multiple states and multiple lambing seasons reveals a 
dramatic shift in the epidemiology of ovine campylobacteriosis and suggests that a 
change in preventative strategies for controlling this disease may be warranted.   
 Much of what is known regarding the pathogenesis of C. jejuni infection is based 
on its role as an intestinal pathogen of man; however, even in this regard, knowledge of 
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the molecular mechanisms employed by this bacterium lags behind that of other enteric 
pathogens.
11
  One significant impediment to the study of Campylobacter pathogenesis is 
the lack of appropriate laboratory animal models that adequately replicate natural 
disease.
11,12
  While it is accepted that in the pathogenesis of ovine campylobacteriosis 
pathogenic Campylobacter spp. must bind to and invade intestinal epithelia, survive the 
host immune response, and disseminate hematogenously to other organs;
13
 knowledge of 
the precise mechanisms underlying each of these requisite steps is vague at best, 
particularly with regard to dissemination and the apparent tropism of certain strains of C. 
jejuni for the fetoplacental unit.     
 
Specific aims 
The overriding goal of the studies described herein was to enhance understanding 
of some of the potential pathologic mechanisms underlying abortion in sheep associated 
with the emergent, tetracycline-resistant clone SA of C. jejuni.  Our central hypothesis for 
this set of studies was that this particular clone is highly pathogenic with marked tropism 
for the fetoplacental unit and resistance to traditional prevention strategies.  To address 
this hypothesis, the following specific aims were set forth:  1) develop an appropriate 
laboratory animal model of abortion following oral inoculation (Chapter 2) and use this 
model to 2) assess the expression of Toll-like receptors in infected versus uninfected 
placentas (Chapter 3), 3) compare the efficacy of commercially available vaccines and an 
experimental bacterin against challenge with the IA3902 isolate of clone SA (Chapter 4), 
3 
 
and 4) investigate the effects of different placental factors and blood and bile from 
pregnant animals on the growth and chemotaxis of C. jejuni IA3902 (Chapter 5).   
 
Dissertation organization 
This dissertation is organized in the alternative format with six chapters.  The first 
chapter (Chapter 1) consists of a general introduction and literature review.  The four 
chapters that follow (Chapter 2 – 5) are comprised of four individual manuscripts, and are 
followed by a final chapter (Chapter 6) containing general conclusions and suggestions 
for future research.  References appear at the end of each chapter.  Two of the 
manuscripts have been published in or accepted for publication in the American Journal 
of Veterinary Research (Chapter 2 and Chapter 4), one has been published in Veterinary 
Pathology (Chapter 3), and the fourth manuscript has been submitted to Veterinary 
Pathology (Chapter 5).   
 
Literature review 
Campylobacter spp.:  General characteristics and zoonotic risk  
Campylobacter spp. are gram-negative, nonsporeforming rods with a 
characteristic curved, spiral or S-shaped morphology and darting motility.
14,15
  Most 
species have a single polar unsheathed flagellum at one (monotrichous) or both 
(amphitrichous) ends of their cells.
15
  Campylobacters are generally microaerophilic, 
nonsaccharolytic, and utilize amino acids and intermediates of the tricarboxylic acid 
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cycle for energy;
16
 however, recent evidence suggests certain strains of C. jejuni have the 
capacity to metabolize L-fucose.
17
  There are currently 17 species in the genus 
Campylobacter
11
 and they are widespread in nature and infect a broad range of hosts 
including birds, animals, and man.
1
  Originally classified in the genus Vibrio, 
campylobacters were later moved to their own genus based on differences in metabolism 
and DNA composition;
18
 as such, much of the early literature bears the former taxonomy 
and disease in animals was historically known as vibriosis.  The predominant 
Campylobacter spp. of importance in veterinary medicine include:  C. fetus, C. jejuni, 
and C. coli.   
C. fetus grows between 25⁰C and 37⁰C,14 and includes two subtypes that are 
frequently implicated in animal abortions:  C. fetus subsp. venerealis and C. fetus subsp. 
fetus.  C. fetus subsp. venerealis is a venereal pathogen of cattle
14,19
 resulting in infertility 
and abortion,
15
 whereas C. fetus subsp. fetus causes contagious abortion in sheep
2,19
 and 
sporadic abortion in cattle,
14,19
 horses,
20
and man.
14,21,22
   
C. jejuni, formerly classified as C. fetus subsp. jejuni,
14
 and the closely related C. 
coli, belong to what is known as the thermophilic group of campylobacters
1
 due to their 
optimal growth at a higher temperature, 42⁰C, than that of other species.  The average 
prevalence of these two thermophilic campylobacters in the feces of domestic cattle, 
sheep, and pigs has been reported to range from 21.9% - 26.7%
23
 and from 18.3% - 
36.6%
24
 while the average reported prevalence for poultry was 41.4%.
23
  C. jejuni is a 
well-recognized and important cause of contagious abortion in sheep
2
 and is also reported 
to cause abortion in cattle,
25,26
 goats,
27
 mink,
28
 and dogs;
29
 whereas C. coli has been 
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associated with abortion in sheep
5
 and man.
30,31
  As a zoonotic pathogen, C. jejuni is best 
recognized as a cause of acute enteritis with profuse, watery diarrhea;
32,33
 however, 
human infection may also lead to a variety of extraintestinal diseases including 
abortion.
21,34-37
   
While poultry products are considered the predominant source in sporadic cases 
of human C. jejuni infection,
38-40
 sheep and cattle intermittently shed Campylobacter spp. 
throughout their lives, often in a seasonal pattern,
41
 and therefore their housing facilities 
and the associated surface and subsurface waters should be considered another potential 
source of human exposure.  Of these two domestic ruminants, sheep would appear to be 
the most significant source of exposure as the average recovered concentration of 
thermophilic campylobacters from the feces of infected flocks was roughly 10-fold 
higher than that from infected cattle.
23
  Additionally, the average isolation rate of 
thermophilic campylobacters from small intestinal contents of lambs at slaughter has 
been reported as high as 91.7%
42
 providing a significant source of potential carcass 
contamination.  Not surprisingly, C. jejuni was isolated from 71.3% of sheep carcasses in 
one abattoir study,
43
 and surveys of retail meat products have reported isolation of C. 
jejuni from 80% of lamb liver samples
44
 and 6.5% of commercial lamb and mutton.
45
  
Finally, flies collected from pastures housing both sheep and cattle have been shown to 
carry viable Campylobacter organisms, including both C. jejuni and C. coli, and may 
therefore serve as yet another potential source of transmittance from infected livestock to 
humans through contact with food and food preparation surfaces.
46
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Ovine campylobacteriosis 
Reproductive disease in sheep associated with infection by Campylobacter spp. 
has long been referred to as epizootic abortion given the classical occurrence of abortion 
outbreaks, or storms, affecting roughly 25% of the flock on average.
47
  Reproductive 
performance is one of the most significant factors affecting the profitability of small 
ruminant operations,
48
 and therefore such epizootics of abortion may lead to severe 
economic losses.
49
  Campylobacter-associated abortion often ranks as one of the top three 
infectious causes of ovine abortion in many parts of the world,
2,8,49-52
 and a 2001 survey
53
 
indicated that Campylobacter spp. were the most commonly reported infectious cause of 
abortion in the United States during the three years preceding the survey.  The incidence 
of abortion within a flock depends upon the number of ewes pregnant beyond the first 
month of gestation and the level of prior exposure to the infecting strain.
47
  Immunity 
after natural infection is achieved even if an animal does not abort during an epizootic.
54
  
Such postinfection immunity has been demonstrated to last at least one year
55
 and is 
thought to last approximately two years on average;
47
 however, given the frequent 
heterogeneity of infectious species
2
 and strains
7,8
 associated with epizootics, the potential 
exists for Campylobacter-associated abortions in successive lambing seasons.  Infection 
is acquired orally, most often following consumption of infected products of parturition;
1
 
however, fecal contamination of water supplies is relatively common
47
 and increased 
fecal shedding has been observed in times of high abortion rates.
1
  Infectious 
Campylobacter spp. have also been recovered from flies captured in grazing areas
46
 and 
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from the feces of infected magpies,
56,57
 crows,
58
 and other birds
59
 revealing additional 
potential means of spread between farms.   
The pathogenesis of ovine campylobacteriosis is thought to entail oral exposure 
and ingestion of contaminated material
60
 with subsequent intestinal colonization, mucosal 
invasion, transient bacteremia
61
 and placental localization.
62
  Gall bladder colonization by 
C. fetus has been reported following natural abortion,
63
 oral inoculation,
63
 and 
intravenous inoculation,
64,65
 and, in ewes intravenously inoculated, gall bladder 
colonization was often associated with concurrent intestinal colonization
65
 thus 
supporting the potential role of gall bladder colonization after bacteremia in the 
development of carrier ewes and overall disease epidemiology.
64
  Indeed, carrier ewes are 
likely an important potential source of disease spread as Campylobacter spp. can be 
recovered from small intestinal contents and bile of apparently healthy sheep at 
slaughter,
66-70
 and C. fetus recovered from the bile can readily induce abortion in ewes.
71
  
In 1976, an Australian survey
67
 revealed potentially pathogenic campylobacters in the 
bile of 3.3% of sheep tested (33/1015) and 91% (30/33) of those isolates were identified 
as C. jejuni.  Infection in ewes is predominantly intestinal, and involvement of the uterus 
is considered by some to be an accidental outcome of bacteremia in nonimmune pregnant 
ewes.
47
  In fact, a period of detectable bacteremia as short as 15 minutes is reportedly 
sufficient for establishing uterine infection in pregnant ewes.
64
  One pivotal step in the 
pathogenesis of Campylobacter-associated abortion is invasion of the intestinal 
epithelium allowing access to the blood stream and systemic spread.  For C. fetus subsp. 
fetus, systemic infection is dependent on the expression of surface layer (S-layer) 
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proteins
72
 which block complement 3b (C3b) binding
73
 and thereby inhibit complement-
mediated killing mechanisms; however, these proteins are not expressed by C. jejuni.   
Much of the research involving pathogenesis of C. jejuni infection has focused on 
intestinal colonization as it relates to human disease.  Human pathogenic isolates of C. 
jejuni have been demonstrated to colonize the intestinal mucus layer,
74
 and a number of 
potential adhesions have been identified which may play a role in adherence to the 
mucosal epithelium, however, their role in disease is uncertain.
11
  Pathogenic isolates of 
C. jejuni are generally considered invasive,
11
 and thought to employ a microtubule-
dependent invasion system,
75
 whereby bacteria are taken into an endosomal vacuole and 
travel along microtubules to the perinuclear area.
76
  These internalized bacteria then 
undergo limited replication within intestinal cells
76
 and move within vacuoles
77
 to the 
basolateral membrane for exocytosis.
75
  The presence of functional flagella is a key factor 
in efficient colonization
78,79
 and cellular uptake of C. jejuni,
80
 while flagellar paralysis 
allows adherence but not invasion of eukaryotic cells.
81
  Many strains of C. jejuni, as well 
as C. coli and C. fetus, produce cytolethal-distending toxin (CDT),
82
 a nuclease capable 
of inducing double strand breaks in DNA of both proliferating and nonproliferating host 
cells, thereby leading to cell cycle arrest or cell death.
83
  Such dead or dying cells within 
the mucosa may provide adequate disruption of the epithelial barrier to allow entry of 
bacteria into the lamina propria.  Both the cellular invasion of C. jejuni and the 
production of CDT alone induce IL-8 secretion by human intestinal cells in vitro,
84
 
suggesting the induction of an active neutrophil response and local containment of 
infection; however, survival of C. jejuni for at least 6 days has been demonstrated within 
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mononuclear phagocytes,
85
 revealing at least one potential method of bacterial survival 
and dissemination.  Taken together, these findings provide a generalized understanding of 
the pathogenesis of septic abortion due to Campylobacter spp.; however, there are still 
key knowledge gaps in the mechanisms underlying each of the requisite steps in this 
process and the observed variation in virulence between Campylobacter species and 
strains.   
Ovine campylobacteriosis manifests as a spectrum of clinical disease including 
late term abortion, stillbirth, premature birth, birth of weak lambs and occasionally 
metritis.
86
  Subclinical infection may also occur with infected ewes delivering clinically 
normal carrier lambs.
47
  Abortion generally occurs 7 to 25 days postexposure,
49
 and it is 
typical for one or two ewes to abort initially, followed by a rapid rise in abortion 
incidence 2 to 3 weeks later.
1
  Large numbers of organisms are generally present within 
aborted materials
49
 and are most readily recovered from the placenta, fetal stomach 
contents and fetal liver, respectively.
1
  Grossly there is placentitis characterized by 
swollen, pulpy cotyledons covered with exudate and an edematous chorionic stroma.
47
  
Lesions are generally focused on the placentomes while the intercotyledonary spaces are 
less severely affected.
47
  Histologically there is arteriolitis,
87
 infiltration of predominantly 
histiocytes,
47
 and often high numbers of bacteria within trophoblasts and endothelial 
cells.
86,87
  Fetal lesions are variable and include nonspecific edema, suppurative 
bronchopneumonia, and occasionally random necrotizing hepatitis with a characteristic 
targetoid gross appearance.
47
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As stated previously, the most common isolates from Campylobacter-associated 
ovine abortions have historically been C. fetus subsp. fetus, C. jejuni, and C. coli, with 
decreasing frequency, respectively;
1,2
 however, several recent studies have demonstrated 
a significant shift in the epidemiology of this disease with C. jejuni becoming 
increasingly more prevalent.
2,8-10
  In one study, not only was C. jejuni the most common 
isolate, but 93% of the isolates were of a single genetic clone, and 100% of the isolates 
were resistant to tetracycline.
10
  The emergence of a single, antibiotic-resistant genetic 
clone of C. jejuni associated with the preponderance of abortions from multiple farms in 
multiple states is intriguing as there has traditionally been significant antigenic and 
genetic heterogeneity among isolates.
3,6-8,88
  Additionally, as tetracyclines are the only 
class of antimicrobials approved for the treatment of campylobacteriosis in sheep,
89
 it 
seems possible that emergence of this particular strain may have at least in part been 
enhanced by chemoprophylaxis.   
Animal models of campylobacteriosis 
One major impediment to the study of C. jejuni pathogenesis has been a lack of 
appropriate animal models.
11,12
  C. jejuni is present in the feces of many domestic and 
wild avian and mammalian species
90-101
 but rarely causes the type of acute enteritis 
observed in humans.
80
  Nonhuman primates are likely the best candidate model for 
studying the pathogenesis of enteric campylobacteriosis
12,102
 but their use carries both 
financial and ethical challenges.  Mustelids present another potential model for study of 
enteric campylobacteriosis as the development of acute enterocolitis has been 
demonstrated in both mink
103
 and ferrets;
104-106
 however, the availability of specific-
11 
 
pathogen-free animals is limited and commercially available ferrets sold for research 
purposes often shed C. jejuni in their feces.
107
  C. jejuni is not a commensal organism of 
laboratory mice,
12,108
 and several studies have shown colonization following oral 
inoculation;
108-110
 however, colonized mice generally lack intestinal pathology.
11
  
Interestingly, bacteremia has been observed in mice orally inoculated with both C. 
jejuni
108,111
 and C. fetus,
112
 suggesting that they, at the very least, may be an effective 
model for studying this aspect of the pathogenesis of systemic campylobacteriosis.   
Research exploring the pathogenic mechanisms underlying ovine 
campylobacteriosis would ideally involve studies in the target species; however, the costs 
of animal housing, the frequency of intestinal and bile colonization in apparently healthy 
sheep,
68,69
 the high cost and low of availability of specific-pathogen-free animals, and 
lengthy gestation are significant impediments.  Therefore, the smaller size, reduced costs 
of housing, and ease of obtaining Campylobacter-negative stock make laboratory animals 
a desirable model for studying specific aspects of disease pathogenesis.  As reproductive 
failure is the predominant disease outcome in affected sheep, an appropriate animal 
model should closely replicate this aspect of the disease.  Abortion due to C. jejuni has 
been reported in farmed mink
28
 and reproductive failure has been experimentally induced 
in ferrets and mink following both intravenous and oral inoculation with C. jejuni;
113
 
however, as stated previously, the use of this model is limited by the availability of 
Campylobacter-negative animals.
107
   
The domestic guinea pig (Cavia porcellus) has a gestation length that varies from 
59 to 72 days (mean 68)
114
 and gives birth to precocious young,
115
 making it closer to the 
12 
 
target species in reproductive behavior than many other laboratory rodents and thereby a 
desirable candidate for studying the pathogenesis of Campylobacter-associated abortion.  
Accordingly, the induction of abortion in pregnant guinea pigs after intraperitoneal (IP) 
inoculation has been used as a screening tool for virulence of C. fetus, C. jejuni, and C. 
coli isolates from both animals and man,
116-119
 and to compare efficacy of commercial 
and experimental Campylobacter vaccines.
120-123
  Pure cultures of C. fetus have been 
recovered from the uterine fluid of both pregnant and non-pregnant guinea pigs which 
were parenterally inoculated with the organism
124
 suggesting a tropism for this 
environment following bacteremia in this species, and C. fetus has been recovered in pure 
culture from the gall bladder of pregnant guinea pigs
124,125
 suggesting the potential for 
localization in this organ similar to what is observed in sheep.  Guinea pigs aborting 
following IP challenge with C. fetus often have pronounced suppurative endometritis and 
uterine edema,
126
 and horizontal transmission of C. fetus has been observed between 
guinea pigs inoculated intravaginally and uninoculated cagemates,
125
 further supporting 
the appropriateness of the guinea pig as a model for study of campylobacteriosis; 
however, these methods do not fully replicate the natural disease process as bacteremia is 
not the result of intestinal invasion with parenteral inoculation and an oral inoculation 
model would seem superior for study of all phases of disease pathogenesis.   
Oral inoculation of guinea pigs has been attempted with human isolates of C. fetus 
and C. jejuni;
119
 however, abortion did not occur in any orally inoculated animals and 
bacteremia was only observed in one animal inoculated with C. fetus compared with 
much higher rates of abortion and bacteremia following IP inoculation with the same 
13 
 
strains.  Abortion was observed in 22% (2/9) of guinea pigs following oral inoculation 
with a combined inoculum of both bovine and ovine origin C. fetus that had been 
subjected to five serial IP guinea pig passages to increase pathogenicity;
124
 however, C. 
fetus was not recovered from the uterus or fetal tissues of either aborting animal, and 
organisms with features consistent with C. fetus were only observed in Gram stained 
smears of uterine contents from one of the aborting animals.  As these previous attempts 
at oral challenge in guinea pigs did not employ a pure culture of an ovine-origin, 
abortion-derived isolate, it remains to be seen if known abortifacient strains would 
behave differently following oral inoculation in pregnant guinea pigs, and further support 
for the appropriateness of a guinea pig oral inoculation model comes from its successful 
employ in the study of disease due to Toxoplasma gondii,
127,128
 another common ovine 
reproductive pathogen.   
Toll-like receptors and the maternofetal interface 
The junction of mother and fetus has often been described as an immunological 
paradox.
129
  While the endometrium must tolerate the implantation of a relatively 
allogenic placenta, it is paramount that immune surveillance be maintained against a 
broad spectrum of potential pathogens, and yet an overactive response may lead to a lack 
of fetal tolerance.  Accordingly, the innate immune system provides the primary defense 
against infection at the maternofetal interface.  Significant numbers of macrophages, 
natural killer (NK) cells and fewer / T cells have been described in the early decidua,130 
and these cells, along with the physical barrier imparted by the placenta, were 
traditionally thought to provide the essential innate immune functions necessary at the 
14 
 
site of implantation.  Recent studies, however, have shown that trophoblasts and decidual 
cells directly participate in the innate immune response through their expression of 
conserved pathogen recognition receptors.
131-133      
The Toll receptor was first identified in Drosophila as a transmembrane receptor 
involved in the establishment of dorsoventral polarity in the developing embryo.
134
  
Continued work with mutant flies revealed that those lacking components of the Toll-
mediated pathway were highly susceptible to fungal and bacterial infections,
135,136
 thus 
demonstrating a link between the Toll-mediated pathway and regulation of immune 
responses in flies.  As the signaling pathway of Toll in Drosophila shares remarkable 
similarity to that of the mammalian interleukin-1 (IL-1) pathway,
137
 it was proposed that 
this might be a conserved signaling pathway, and, indeed, a mammalian homologue of 
the Drosophila Toll protein was later identified
138
 and then further expanded into a 
family of proteins known as Toll-like receptors (TLRs).
139-142
  
TLRs are well-characterized pattern recognition receptors (PRRs) that each 
recognize specific, highly conserved pathogen-associated molecular patterns (PAMPs), 
play a key role in innate immune function, and have been extensively reviewed.
143-146
  In 
brief, there are 10 members of the TLR family (TLRs 1-10) that have been identified in 
cattle, swine, sheep, mice and humans, each sharing a high degree of genetic sequence 
similarity across species.
147
   TLRs can be grouped based on their location of cellular 
expression with TLRs 1, 2, 4, 5 and 6 being expressed at the cell surface, while TLRs 3, 
7, 8, and 9 are expressed intracellularly.
146
  TLRs are expressed on both immune and non-
immune cells, and most tissues express at least one TLR.
148
  Among the TLRs, TLR2 has 
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the widest range of known ligands including PAMPs from gram-positive bacteria, gram-
negative bacteria, mycobacteria and mycoplasma,
144
 and this is likely made possible, at 
least in part, through its formation of heterodimers with either TLR1 or TLR6.
149,150
  
Other well known PAMPS and their corresponding TLRs include lipopolysaccharide 
(LPS) and TLR4,
151
 flagellin and TLR5,
152
 and pathogen-associated nucleic acid patterns 
and TLRs 3, 7, 8, and 9.
143
   
While each TLR binds a unique set of PAMPs, most TLRs signal through a 
common intracellular pathway.
144
  With the exception of TLR3, all TLRs interact with 
myeloid differentiation factor 88 (MyD88) which recruits the IL-1 receptor associated 
kinase (IRAK).
153
  Once phosphorylated, IRAK associates with tumor necrosis factor 
receptor-associated factor 6 (TRAF6) and leads to downstream activation of c-Jun N-
terminal kinase (JNK) and nuclear factor-kappa B (NF-B).144  Activation of these 
transcription factors generally leads to the production of inflammatory cytokines such as 
TNF-, IL-1β, and IL-6.154  Additionally, TLR-3 and TLR-4 have been shown to signal 
through a MyD88-independent pathway by their association with Toll/IL-1R domain-
containing adaptor inducing
 
IFN-  (TRIF)
155
 which, through TANK-binding kinase 
(TBK-1), activates the transcription factor interferon regulatory factor 3 (IRF-3).
156
  
Activation of IRF-3 leads to the production of the type-I interferons, IFN- and IFN-.154 
Expression of mRNA for TLRs 1-10 has been demonstrated in human term 
placental tissues,
148
 and multiple immunohistochemical studies have revealed the 
expression of TLR2 and TLR4 protein in both first trimester and term placenta.
133,157,158
  
Immunohistochemistry of first trimester placental tissues has further revealed that both 
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TLR2 and TLR4 are highly expressed in villous cytotrophoblasts and extravillous 
trophoblasts, but are absent in the syncytiotrophoblast,
159
 suggesting the early 
syncytiotrophoblast may serve solely as a barrier to infection and does not actively 
participate in the TLR response.  Therefore, TLRs expressed in villous cytotrophoblasts 
will respond to a pathogen only once it has successfully penetrated the 
syncytiotrophoblast barrier.  In contrast, studies of term placental tissue have revealed 
significant immunoreactivity for TLR2 and TLR4 in extravillous trophoblasts and the 
syncytiotrophoblast, but not in the villous cytotrophoblast cells.
157,158
  Another study,
160
 
confined to TLR2, was consistent with this shift, demonstrating positive TLR2 
immunoreactivity in all trophoblast layers of second trimester placentas except the 
syncytiotrophoblast, with a shift to positive syncytiotrophoblast immunoreactivity in the 
term placenta.  Whether this shift in TLR distribution reflects a true developmental 
change in the placenta, or simply variability in experimental technique, remains to be 
seen; however, this phenomenon is intriguing when compared with the epidemiology of 
bacterial-induced adverse pregnancy responses at various points during gestation, 
particularly the number of pathogens that are associated with late term disease.   
In a more detailed immunohistochemical analysis of TLR4 expression,
161
 
cytoplasmic reactivity was observed in the syncytiotrophoblast of both first trimester and 
term placenta, with greater expression in the term tissues.  Additionally, darker staining 
was observed at the maternal facing plasma membrane versus the basal membrane, and 
this polarized staining pattern suggests greater expression at the surface which is 
continuously exposed to maternal blood and supports the involvement of TLR4 in the 
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initiation of a rapid response to maternal bacterial infection, particularly late in 
gestation.
161
  Demonstration of constitutive expression of TLR4 in human extravillous 
trophoblast cells, regardless of gestational stage,
162
 suggests a role for these cells as part 
of the first line of defense against invading pathogens at the maternofetal interface; a role 
further supported by the considerable over-expression of TLR4 in these cells during 
inflammatory states, such as preeclampsia, that are associated with high levels of TNF-
.163 
In vitro investigation of the response of trophoblast cells derived from different 
stages of gestation to binding of TLR2 and TLR4 with their respective ligands has 
revealed significant gestational-stage-dependent differences.  For example, in human first 
trimester trophoblast cells, which lack TLR6, TLR2 ligation by either peptidoglycan or 
lipoteichoic acid triggers apoptosis rather than the classical cytokine upregulation 
observed in other tissues,
159
 and this TLR2-induced apoptosis is mediated by MyD88 
recruitment of the Fas-associated protein with death domain (FADD) and the initiation of 
the caspase cascade.
133
  In contrast, term placental explants
157
 and first trimester 
trophoblast cells transfected to express TLR6
164
 produce the proinflammatory cytokines 
IL-6 and IL-8 when exposed to known TLR2 ligands.  As term placental cytotrophoblast 
cells have been shown to express TLR6,
165
 these findings suggest that when trophoblasts 
are exposed to certain TLR2 ligands the presence or absence of TLR2/TLR6 
heterodimers may be key in determining whether the exposed trophoblasts secrete 
cytokines or undergo apoptosis, respectively.  The response of trophoblast cells to TLR4 
ligation by LPS appears more consistent throughout gestation as exposure of first 
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trimester trophoblast cells to LPS results in the production of high levels of the cytokines 
TNF- and INF-,159 and exposure of term placental explants to LPS results in the 
production of the proinflammatory cytokines IL-6 and IL-8.
157
  While TLR4 ligation by 
LPS does not directly induce trophoblast apoptosis,
159
 the resultant high levels of TNF- 
and INF- have been shown to increase the sensitivity of trophoblast cells to Fas-
mediated apoptosis,
166
 and recent work with Chlamydia trachomatis has revealed that 
TLR4 not only binds LPS, but also chlamydial heat shock proteins (cHSPs) and that 
cHSP60 binding in particular can trigger caspase-induced apoptosis in second trimester 
trophoblast cells.
167
  As such, TLR ligation in trophoblast cells appears to have the 
capacity to induce both apoptosis and cytokine release with the outcome dependent upon 
gestational stage and ligand composition.   
Decidual cells express mRNA for TLRs 1-10,
131
 and protein expression has been 
observed for TLRs 1-6;
168
 however, there is limited work involving the effects of ligand 
binding in decidual cells,
169
 and the results are somewhat conflicting.  In one study,
131
 
exposure of human decidual cells to peptidoglycan, a known TLR2 ligand, failed to 
induce production of either IL-6 or IL-8, while exposure to LPS induced significant 
levels of IL-6 and modestly increased IL-8.  In contrast, in this same study, exposure of 
decidual cells to either ligand induced nuclear translocation of NF-B,131 a critical step in 
the TLR signaling process.  Additionally, in a separate study,
168
 exposure of decidual 
cells to either LPS or peptidoglycan resulted in significantly increased levels of IL-8.  
Thus, it seems clear that LPS has the capacity to induce a proinflammatory cytokine 
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response in decidual cells by way of TLR4, while the effects of TLR2 ligation are less 
clear.  
Previous studies have revealed that TLR2 and TLR4, but not TLR5 are capable of 
binding PAMPs of Campylobacter spp.  Unlike many other flagellated bacteria, the 
flagellin produced by C. jejuni does not effectively bind TLR5,
170
 and both live and lysed 
C. jejuni fail to induce TLR5-dependent cytokine expression in human and chicken 
cells.
171
  C. jejuni and C. coli both induce IL-8 secretion by human intestinal epithelial 
cells in a TLR-mediated, MyD88-dependent manner requiring the presence of functional 
flagella and CDT,
172
 and the production of IL-6 by human intestinal epithelia has been 
described through the interaction of C. jejuni surface polysaccharides and TLR2.
173
  
Interestingly, lysed C. jejuni cells are reported to be more effective than live bacteria in 
inducing TLR2 and TLR4 dependent cytokine responses in both chicken and human 
cells,
171
 suggesting that bacterial lysis may actually enhance the TLR-stimulative 
potential of C. jejuni.  Activation of dendritic cells by C. jejuni is significantly reduced in 
the absence of TLR2, TLR4, MyD88 and TRIF indicating that all four components are 
important in maximal signaling of these cells following C. jejuni challenge.
174
  Lastly, C. 
rectus infection has been associated with increased expression of TLR4 protein in 
trophoblasts of the murine placental labyrinth.
175
    
Vaccination in the prevention of ovine campylobacteriosis   
In the 1960s, Miller and Jensen first described the potential for control of ovine 
campylobacteriosis through vaccination.
176,177
 Administration of two subcutaneous doses 
prior to breeding of either live C. fetus organisms or a whole-cell, formalin-killed C. fetus 
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bacterin, resulted in 100% and 72% protection, respectively, against homologous oral 
challenge during the fifth month of gestation; whereas only 16% of the unvaccinated 
controls failed to abort.
176
  With the addition of mineral oil or aluminum as an adjuvant, 
the protection imparted by killed C. fetus bacterins was enhanced to 100% and 96%, 
respectively, in the face of homologous oral challenge and required just a single dose of 
the bacterin;
177
 however, the level of protection fell to 14 - 59% against heterologous 
serotypes.
178
  Storz et al. expanded upon these findings by revealing that when two doses 
of a monovalent, aluminum adjuvanted, C. fetus bacterin were administered 3 weeks 
apart, 75% of the flock remained protected against homologous challenge 41 months 
postvaccination.
179
  In light of this prolonged immunity, Storz et al. further showed that 
vaccinating only the replacement ewes within a herd, once at 18 months of age and once 
prior to breeding, was effective in preventing epizootics of abortion in the herd for up to 
five years.
180
   
The antigens of C. fetus important for conferring resistance to disease in sheep 
may be capsular antigens, flagellar antigens, or both,
181
 and the intact bacterium is not 
required for the development of immunity as 100% protection from abortion has been 
reported in ewes administered two doses of a cell-disrupted, formolized, adjuvanted 
vaccine and later challenged with a homologous strain.
182
  There is also evidence that 
antibody to S-layer proteins is effective in preventing abortions due to C. fetus, and that 
conserved regions within S-layer proteins may offer some cross protection between 
heterologous serotypes.
183
  In the evaluation of serologic responses of sheep to 
vaccination with three separate monovalent cell-disrupted bacterins, slight agglutination 
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titers to heterologous serotypes were observed, again suggesting that there may be some 
antigenic overlap between serotypes.
184
   
In efforts to maintain profitability, it is imperative that sheep producers keep fixed 
costs at a minimum.  As such, the benefits of potential vaccines are often weighed against 
their cost and the potential risk for disease occurrence, and it is often desirable to 
administer vaccines as combination products.  Indeed, Campylobacter vaccines have 
been described containing multiple serotypes
178,184
 and strains,
121,185
 or in combination 
with the agent of enzootic abortion, Chlamydophila psittaci.
185-187
  While vaccination can 
be effective in the prevention of ovine campylobacteriosis, it is by no means a panacea.  
Experimental studies have demonstrated inadequate protection, even in the face of 
homologous challenge, in ewes vaccinated with commercial bacterins of questionable 
efficacy,
188
 and in those vaccinated with experimental bacterins and subsequently 
challenged with heterologous serotypes.
178
  Additionally, field cases of Campylobacter-
associated abortion have been reported in flocks receiving commercial monovalent
189
 and 
bivalent
9
 vaccines, and there are reports of an increased incidence of isolation of non-
vaccine strains from epizootics of abortion in New Zealand.
190
  Accordingly, no single 
vaccine will likely be protective against all abortifacient Campylobacter spp., and 
continued efficacy testing is required to monitor the usefulness of a given vaccine.   
Large scale efficacy testing of Campylobacter vaccines in the target species 
would be cost prohibitive.  As such, the pregnant guinea pig has been described as an 
effective laboratory animal model for testing the efficacy of commercial Campylobacter 
vaccines intended for cattle
120,121
 and sheep,
121
 as well as experimental bacterins.
122,123
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These efficacy studies have revealed that immunization with a monovalent bacterin of 
either C. fetus or C. jejuni is not cross protective against challenge with the opposite 
species,
123
 and that protection is lower when challenged with a heterologous strain of the 
same species.
122,123
  These findings provide further support for the use of multivalent 
vaccines in the prevention of ovine campylobacteriosis. 
In an effort to develop an alternative to traditional vaccination strategies, a group 
of ewes was experimentally infected with C. fetus and later vaccinated with a single dose 
of a formalized, disrupted cell, homologous bacterin immediately after the onset of the 
first abortion within the group, and this treatment effectively reduced subsequent 
abortions in the remaining ewes.
191
  These findings were confirmed in field cases where 
treatment with two doses ten days apart was effective in curbing additional abortions 
within a flock if administered at the time of indicator abortion; however, no effect was 
observed if treatment was delayed until 2 weeks after the indicator event.
192
  These 
findings suggest that, if administered early, vaccination in the face of an epizootic may be 
an effective tactical strategy to control losses due to campylobacteriosis while 
minimizing costs.  
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Abstract 
Objective—To compare pathogenicity of an emergent abortifacient 
Campylobacter jejuni (IA3902) with reference strains after oral inoculation in pregnant 
guinea pigs. 
Animals—58 pregnant guinea pigs. 
Procedures—Twelve animals were challenged IP with Campylobacter jejuni 
IA3902 along with 5 sham-inoculated controls to confirm abortifacient potential.  Once 
pathogenicity was confirmed, challenge via oral inoculation was performed whereby 12 
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animals received IA3902, 12 received C. jejuni isolated from ovine feces (OF48), 12 
received a fully sequenced human C. jejuni isolate (NCTC 11168), and 5 were sham-
inoculated controls.  After abortions, animals were euthanized and samples were 
collected for microbial culture, histologic examination, and immunohistochemical 
analysis. 
Results—C. jejuni IA3902 induced abortion in all 12 animals following IP 
inoculation and 6 of 10 challenged orally.  All 3 isolates colonized the intestine after oral 
inoculation, but only IA3902 induced abortion.  There was evidence of systemic infection 
for both IA3902 and NCTC 11168; however, C. jejuni was only recovered from 
fetoplacental units of animals inoculated with IA3902.  Immunohistochemical analysis 
localized C. jejuni IA3902 infection to subplacental trophoblasts, perivascular tissues, 
and phagocytes in the placental transitional zone. 
Conclusions and Clinical Relevance—This study revealed that C. jejuni IA3902 
is a unique, highly abortifacient strain with the ability to colonize the intestines, induce 
systemic infection, and cause abortion because of its affinity for the fetoplacental unit.  
Guinea pigs could be effectively used in the study of septic abortion after oral inoculation 
with this Campylobacter strain.  
 
Introduction 
Abortions in sheep as a result of campylobacteriosis are common throughout the 
world, with regional variability in the species isolated and abortion rate.
1
  In a 2001 
survey
2
 that spanned 22 states and included 72.3% of US sheep producers, 
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campylobacteriosis was reported as the most common cause of infectious abortion in 
domestic flocks, with 53.7% of those reports confirmed by a veterinarian or diagnostic 
laboratory.  Historically, Campylobacter fetus subsp. fetus was the predominant isolate in 
sheep with campylobacteriosis, whereas Campylobacter jejuni and Campylobacter coli 
accounted for a smaller percentage.
3–6
  However, 2 US studies
7,8
 have indicated a 
dramatic shift in this relationship, with C. jejuni becoming the predominant species 
causing abortion in sheep.  Abortion-causing isolates of C. fetus subsp. fetus and C. jejuni 
have considerable heterogeneity.
9–11
  Analysis by use of pulsed-field gel electrophoresis 
has revealed a major shift in the distribution of isolates.  An initial study
8
 of C. jejuni 
isolates from aborting ewes in Iowa flocks had a preponderance of a single clone despite 
recovery from multiple Iowa farms during multiple lambing seasons.
8
  Expansion of this 
evaluation confirmed that this single clone of tetracycline-resistant C. jejuni was the 
predominant Campylobacter strain isolated from abortions of sheep in South Dakota, 
Idaho, California, Oregon, and Nevada.
8
  These findings strongly suggest that a highly 
abortifacient clone of C. jejuni (named clone SA for Sheep Abortion) has emerged that is 
now a leading cause of abortion outbreaks in sheep in the United States. 
Intraperitoneal inoculation of pregnant guinea pigs has been used as a method to 
evaluate the pathogenicity of Campylobacter spp.
12,13
 and to assess the efficacy of 
vaccines.
14–16
  Their small size, ease of housing, and relatively short duration of gestation 
make guinea pigs a desirable animal for use in studying Campylobacter-induced abortion, 
particularly when compared with the use of sheep or goats, which are the species most 
commonly affected in nature.  However, an IP technique is not totally appropriate for use 
42 
 
in evaluating the pathogenesis of septic abortions attributable to C. jejuni because it 
bypasses critical initial steps in the abortion process, including intestinal colonization and 
bacterial invasion.  Currently, there is limited data regarding oral inoculation of C. jejuni 
in guinea pigs.  In another study,
17
 oral inoculation of 4 pathogenic isolates of C. jejuni 
obtained from the intestines of humans failed to induce abortion in pregnant guinea pigs.  
We hypothesize that this was attributable to differences in virulence among C. jejuni 
isolates and that highly abortifacient clinical isolates, such as C. jejuni IA3902, should be 
effective in inducing abortion after oral inoculation.  
In the study reported here, we compared C. jejuni IA3902, a clinical isolate of 
clone SA, with an isolate obtained from the feces of sheep (C. jejuni OF48) and an isolate 
obtained from humans (C. jejuni NCTC 11168) to determine their ability to induce 
abortion after oral inoculation in pregnant guinea pigs.  In all guinea pigs that aborted, 
immunohistochemical analysis was used to identify and localize organisms within 
placental tissues to provide insights into mechanisms involved in Campylobacter-induced 
abortion. 
 
Materials and Methods 
Animals—Fifty-eight pregnant Hartley guinea pigs (approx. 2 to 3 weeks of 
gestation) were obtained from a commercial source
a
 for use in the study.  Seventeen 
guinea pigs were used in a preliminary IP challenge experiment.  Mean weight at time of 
arrival for these guinea pigs was 865 g.  Subsequently, 41 pregnant guinea pigs were used 
in an oral challenge experiment.  Mean weight at time of arrival for these guinea pigs was 
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797 g.  At arrival, a rectal swab specimen was obtained from each guinea pig, placed in 
transfer medium, and plated for Campylobacter culture. 
Guinea pigs were housed in standard metal cages with wood chip bedding and fed 
a pelleted commercial diet formulated for guinea pigs.  Animals were housed in groups (4 
or 5 guinea pigs/cage for the IP challenge exposure and 3 or 4 guinea pigs/cage for the 
oral challenge exposure) and allowed to acclimate to their environment for 7 days prior to 
inoculation.  During this time, weights were recorded daily and guinea pigs were marked 
with black hair dye to provide unique identification for each animal.  For the oral 
challenge exposure, treatment groups were housed in separate banks of cages, and strict 
hygiene was used between handling of groups to prevent cross-contamination.  All 
procedures were approved by the Institutional Animal Care and Use Committee at Iowa 
State University. 
Campylobacter strains—C. jejuni isolates were used in challenge exposures. The 
IA3902 isolate was cultured from an aborted ovine fetus.  This tetracycline-resistant 
strain of C. jejuni is the predominant genetic clone associated with abortion in sheep, as 
determined by pulsed-field gel electrophoresis, multilocus sequence typing, and cmp gene 
sequence typing.
8
  The OF48 isolate was cultured from feces of a sheep that did not have 
clinical signs (abortion or diarrhea).  The NCTC 11168 isolate
b
 is from humans and has 
been completely sequenced.
18
  Fresh bacterial cultures were obtained following 24 hours 
of growth on MH agar in anaerobic jars under microaerobic conditions (5% oxygen, 10% 
carbon dioxide, and 85% nitrogen) at 42
o
C.  These cultures were collected and placed in 
MH broth, diluted to desired concentrations on the basis of optical density, and then used 
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as inocula in the challenge experiments.  The final number of organisms in each 
suspension was determined by counting the number of viable CFUs. 
IP challenge exposure—Two groups of guinea pigs were used in a preliminary 
experiment.  The first group (which comprised 5 guinea pigs) served as sham-inoculated 
control animals and were inoculated IP with 1.0 mL of MH broth, whereas the second 
group (which comprised 12 guinea pigs) was inoculated IP with 1.0 mL of 1.5 X 10
5
 
CFUs of C. jejuni IA3902/mL of MH broth.  This concentration was chosen on the basis 
of reports
12,13
 in which pregnant guinea pigs were challenge exposed with C. jejuni via IP 
inoculation.  Guinea pigs in both groups were inoculated by use of 1-mL tuberculin 
syringes with a 26-gauge, 3/8-inch needle. 
Oral inoculation—Four groups of guinea pigs were used in the oral challenge 
exposure experiment.  The first group (n = 5 guinea pigs) served as sham-inoculated 
control animals and received 1.0 mL of MH broth.  The second group (n = 12 guinea 
pigs) received 1.0 mL of 5.5 X 10
8
 CFUs of C. jejuni OF48/mL of MH broth.  The third 
group (n = 12 guinea pigs) received 1.0 mL of 5.9 X 10
8
 CFUs of C. jejuni NCTC 
11168/mL of MH broth.  The fourth group (n = 12 guinea pigs) received 1.0 mL of 6.0 X 
10
8
 CFUs of C. jejuni IA3902/mL of MH broth.  These doses were chosen to 
approximate those used in other experiments in which C. jejuni was administered orally 
to pregnant ferrets
19
 and guinea pigs.
17
  Guinea pigs in all 4 groups were inoculated orally 
via a curved, 18-gauge, 3-inch, stainless-steel feeding needle.  Food was withheld from 
the guinea pigs for 12 hours prior to inoculation to diminish the amount of food retained 
in the oral cavity. 
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Monitoring, euthanasia, necropsy, and collection of samples—After 
inoculation, guinea pigs were weighed daily by use of a digital gram scale and were 
observed at least twice daily for signs of abortion or impending abortion.  These signs 
included vaginal bleeding, expelled fetuses or fetal membranes, and sudden substantial 
weight loss (> 10% in 24 hours).  Once a guinea pig had aborted or an impending 
abortion was identified, that animal was euthanized via IP injection of sodium 
pentobarbital (approx. 150 mg/kg) and immediately necropsied.  All guinea pigs that had 
not aborted were euthanized 21 days after inoculation and necropsied.  
Necropsy of guinea pigs involved inspection for gross lesions and collection of 
samples for bacterial culture and histologic examination.  Rectal swab specimens for 
Campylobacter culture were obtained by use of sterile minitip cotton swabs
c
 immediately 
after euthanasia.  Other samples harvested for Campylobacter culture included heart 
blood, bile, and uterine tissue from each dam and placenta, liver, and lung tissues from 
each fetus.   Pooled fetal stomach contents were collected only during the oral challenge 
study.  Heart blood, bile, and fetal stomach contents were collected by use of a sterile 
tuberculin syringe with a 26-gauge, 3/8-inch needle.  Samples of uterine, placental, and 
pooled fetal liver and lung tissues were placed in separate sterile plastic bags
d
 (IP 
challenge) or separate sterile Petri plates (oral challenge).  All samples were refrigerated 
until immediately prior to culture, with bacterial culture performed on most samples on 
the day of collection.  
Samples collected for histologic examination included liver, gallbladder, and 
uterine tissues for each dam and placenta, liver, and lung tissues for each fetus.  Samples 
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obtained for histologic examination were placed in neutral-buffered 10% formalin for 24 
hours, embedded in paraffin, and processed routinely for H&E staining. 
Campylobacter culture and semiquantitative enumeration of C. jejuni from 
necropsy samples—A few drops of each fluid sample (blood, bile, or fetal stomach 
contents) were placed directly onto culture media and streaked by use of sterile cotton 
swabs.  Rectal swab specimens were streaked directly onto culture media.  Uterine 
tissues, pooled fetal liver and lung tissues, and placental tissues were minced with a 
scalpel or scissors; then, swab specimens were obtained from the minced tissues by use 
of a sterile cotton swab and streaked onto culture media.  All samples were spread onto 
MH agar containing a Campylobacter selective supplement
e
 (polymyxin B, rifampicin, 
trimethoprim, and cycloheximide) and a Campylobacter growth supplement
f
 (sodium 
pyruvate, sodium metabisulfite, and ferrous sulfate) and were incubated for 48 hours in 
anaerobic jars under microaerobic conditions at 42
o
C.  After incubation, Campylobacter-
like colonies on each plate were counted to determine the number of CFUs in each 
sample. 
Histologic scoring of uterine lesions—Endometrial inflammation was evaluated 
by calculating the mean number of leukocytes in 10 hpfs (40X magnification).  Uterine 
lesions were scored in each hpf by use of the following criteria: 0 = inflammatory 
infiltrate was not identified, 1 = < 10 leukocytes/hpf, 2 = 10 to 20 leukocytes/hpf, and 3 = 
> 20 leukocytes/hpf.  An additional 0.5 points was added to the score when the 
inflammation extended into the underlying myometrium. 
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Immunohistochemical analysis—Placental samples were collected at necropsy 
and embedded in paraffin as described previously.  Tissues were sectioned at a thickness 
of 3 m, mounted on aminoalkylsilane-coated glass slides, and placed in an oven at 56oC 
for 2 hours.  Sections were routinely deparaffinized in xylene and rehydrated in graded 
alcohol solutions and water baths.  Endogenous peroxidase inhibition was achieved by 
immersion (2 immersions; 10 min/immersion) in baths of 3% H2O2 in water.  Sections 
were incubated with 0.1% protease in a Tris buffer (pH, 7.6) at 37
o
C for 15 minutes.  
Slides were rinsed 3 times in PBS solution and then were placed in an automated cell 
staining system.
g
  To inhibit nonspecific binding, sections were incubated in 10% neutral 
goat serum at 22
o
C for 20 minutes.  The primary antibody, which was directed against the 
major outer membrane protein of C. jejuni, was prepared as described in another study.
20
  
This antibody was used at a dilution of 1:300; slides were incubated at 22
o
C for 60 
minutes followed by rinsing in a bath of PBS solution for 5 minutes.  A commercially 
available biotinylated secondary antibody
h
 was used at a dilution of 1:80; slides were 
incubated at 22
o
C for 15 minutes followed by rinsing in a bath of PBS solution for 5 
minutes.  Sections were then incubated with horse radish peroxidase–streptavidin 
conjugate
i
 at 22
o
C for 15 minutes followed by rinsing in a PBS bath for 5 minutes.  The 
final reaction was developed by use of a commercial chromogen.
j
  Sections were rinsed 
and routinely counterstained with Shandon Harris hematoxylin
k
 and Scott’s tap water.  
Sections were dehydrated through graded alcohol and xylene solutions prior to mounting.  
Positive control samples were obtained from paraffin blocks of ovine placental tissues 
that had positive results when cultured for C. jejuni IA3902.  Negative control samples 
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consisted of sections from culture-negative tissues obtained from nonaborting guinea pigs 
inoculated with C. jejuni IA3902 and from sham-inoculated control guinea pigs. 
Statistical analysis—A commercial statistical software packagel was used to 
perform all tests.  Chi-square analysis and Fisher’s exact test for binomial variables were 
employed when comparing abortion rate, incidence of necrotizing hepatitis, and 
incidence of necrosuppurative placentitis between groups, and a 1-way ANOVA was 
used to detect differences in mean uterine scores among groups.  Results were considered 
significant at values of P  0.05. 
 
Results 
IP challenge exposure—All rectal swab specimens collected before challenge 
exposure had negative results when cultured for Campylobacter spp.  Ten of 12 guinea 
pigs inoculated with IA3902 aborted, with 8 guinea pigs aborting 2 or 3 days after 
inoculation and the remaining 2 guinea pigs aborting 8 days after inoculation.  Necropsy 
revealed that the 2 guinea pigs that did not abort were not pregnant; 1 of these guinea 
pigs had a teratoma of the left ovary.  For the control group, none of the 5 guinea pigs 
aborted, and necropsy revealed that all 5 were pregnant.  
Calculation of the abortion rate excluded the 2 guinea pigs that were not pregnant.  
Thus, the abortion rate for guinea pigs inoculated IP with IA3902 (10/10) was 
significantly (P  .001) higher than the abortion rate for the control guinea pigs (0/5). 
Oral challenge exposure—All rectal swab specimens collected before challenge 
exposure had negative results when cultured for Campylobacter spp.  Six of 12 guinea 
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pigs inoculated with IA3902 aborted; 4 guinea pigs aborted between 4 and 6 days after 
inoculation, and the other 2 guinea pigs aborted between 7 and 10 days after inoculation.  
None of the guinea pigs in the remaining groups aborted.  Necropsy revealed that 2 
guinea pigs in each of the IA3902, NCTC 11168, and OF48 groups and 1 guinea pig in 
the control group were not pregnant; we determined that these guinea pigs had not been 
pregnant on the basis of a lack of appreciable weight gain during the study.  These guinea 
pigs were excluded from the calculations for abortion rate.  
Abortion rates differed significantly (P  0.001) among groups (Table 1).  The 
abortion rate for guinea pigs inoculated with IA3902 (6/10) was significantly (P  0.001) 
higher than the rate for any of the other 3 groups (0/10, 0/10, and 0/4 for guinea pigs 
inoculated with NCTC 11168, OF48, or a sham inoculation, respectively).  In addition, 
necropsy revealed that 1 of the 4 remaining pregnant guinea pigs from the IA3902 group 
had histologic and bacteriologic evidence of fetal infection.  
Gross liver lesions consisted of multiple, variably sized, round, white foci; they 
were identified in 9 guinea pigs inoculated with IA3902 and 3 guinea pigs inoculated 
with NCTC 11168.  The predominant histopathologic liver lesion was random, multifocal 
to coalescing hepatitis, which was detected in decreasing frequency in the IA3902 
(11/12), NCTC 11168 (8/12), and OF48 (4/12) groups; this lesion was not detected in the 
control group (0/4).  Inflammatory foci were variably sized, and the associated infiltrate 
differed depending on the interval between challenge exposure and necropsy.  In guinea 
pigs that aborted within a few days after challenge exposure, inflammatory foci were 
primarily heterophilic.  As the interval between challenge exposure and abortion 
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increased, the infiltrate became dominated by lymphocytes, plasma cells, and 
macrophages.  
Incidence of multifocal random hepatitis differed significantly (P < 0.01) among 
groups.  The incidence of random hepatitis was significantly (P < 0.01) higher in the 
IA3902 group, compared with the incidence for the OF48 and control groups; however, 
incidence did not differ significantly (P > 0.1) from the NCTC 11168 group.  Incidence 
of random hepatitis was significantly (P = 0.021) higher in the NCTC 11168 group 
compared with the incidence for the control group, but did not differ significantly (P > 
0.1) from the OF48 group.  Incidence of random hepatitis for the OF48 group did not 
differ significantly (P = 0.182) from the incidence for the control group.  
Mild periportal infiltrates of lymphocytes and plasma cells were detected in most 
of the samples from all groups (Table 1).  Additionally, congestion or edema of the gall 
bladder were evident in 5 guinea pigs of the IA3902 group, 5 guinea pigs of the NCTC 
11168 group, 3 guinea pigs of the OF48 group, and 1 guinea pig of the control group. 
Uterine lesions were variable and consisted of suppurative endometritis, metritis, 
and hemorrhage of varying severity.  Uterine edema was evident in guinea pigs from all 
the IA3902, NCTC 11168, and OF48 groups but was most severe in those from the 
IA3902 group.  In general, uterine inflammatory scores were highest in guinea pigs 
inoculated with IA3902 (mean 2.3; range, 1.0 to 3.5), with lower scores in a few guinea 
pigs of the OF48 (mean 0.4; range, 1.0 to 2.5) and control (mean 0.5; range, 1.0 to 1.5) 
groups and no metritis detected in the NCTC 11168 group.  
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Mean uterine scores differed significantly (P  0.001) among groups (Table 1).  
Mean uterine score for the IA3902 group was significantly (P  0.001) higher than the 
mean uterine score of any of the other 3 groups, whereas the mean uterine scores for the 
NCTC 11168 and OF48 groups did not differ significantly (P = .294 and P = 0.792, 
respectively) from the mean uterine score for the control group.  
Microscopic placental lesions consisted of a combination of hemorrhage, 
suppurative inflammation, and necrosis (Figure 1).  Placental lesions were evident in 8 
guinea pigs inoculated with IA3902 (including all 6 that aborted) and in 1 guinea pig 
inoculated with NCTC 11168.  These changes were detected in both the maternal and 
fetal portions of the placenta, with severity of the lesions increasing with an increase in 
the number of days after inoculation.  
The incidence of necrosuppurative placentitis differed significantly (P  0.001) 
among groups (Table 1).  Incidence of placentitis in the IA3902 group (8/10) was 
significantly (P = 0.006, P = 0.001, and P = 0.015, respectively) higher than the 
incidence for the NCTC 11168 (1/10), OF48 (0/10), and control (0/4) groups; whereas 
incidence for the NCTC 11168 and OF48 groups did not differ significantly (P > 0.999), 
compared with the incidence for the control group.  
High numbers of C. jejuni were cultured from 7 of 10 placental samples, 6 of 10 
fetal liver or lung samples, and 6 of 10 uterine samples in the IA3902 group.  Moderate 
numbers of C. jejuni were cultured from 10 of 12 rectal swab specimens in the IA3902 
group, and low numbers of C. jejuni were generally cultured from 5 of 12 heart blood 
samples, 4 of 9 fetal stomach contents samples, and 2 of 12 bile samples in the IA3902 
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group.  Low to moderate numbers of C. jejuni were cultured from 9 of 12 rectal swab 
specimens from the NCTC 11168 group and 6 of 12 rectal swab specimens from the 
OF48 group.  C. jejuni was not cultured from any other tissues in these groups or from 
any samples collected from the control group.  The percentages of samples with positive 
results for culture of C. jejuni were summarized (Figure 2).  The source and number of 
CFUs for bacterial cultures of guinea animals inoculated with IA3902 were also 
summarized (Table 2). 
Immunohistochemical analysis—Immunohistochemical analysis for C. jejuni 
was performed on all available placental tissues from guinea pigs that aborted during the 
study.  Staining for C. jejuni was not detected in any negative control samples or culture-
negative aborted tissues.  In guinea pigs inoculated IP with IA3902, staining for C. jejuni 
was evident in 5 of 6 culture-positive samples (placental tissues or fetal tissues when 
placental samples were not available for culture).  In guinea pigs inoculated orally with 
IA3902, staining for C. jejuni was evident in 5 of 7 culture-positive samples.  C. jejuni 
organisms were identified within the cytoplasm of subplacental trophoblasts, within 
phagocytes, and in extracellular spaces surrounding trophoblasts in areas of placentitis 
and necrosis (Figure 1).  Organisms were most prevalent at the periphery of the 
subplacenta within the junctional zone.  Multifocal intracellular organisms were also 
detected within the deeper portions of the endometrium and myometrium and 
surrounding the uteroplacental arteries; however, this distribution was limited to samples 
from guinea pigs that aborted at longer intervals after inoculation. 
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Discussion 
Campylobacteriosis has been described as the most common cause of infectious 
abortion in sheep in the United States,
2
 and C. jejuni has become the predominant 
species.
7,8
  Pulsed-field gel electrophoresis, multilocus sequence typing, and cmp gene 
sequence typing of C. jejuni isolates from multiple farms in multiple states during 
multiple lambing seasons have revealed that most of these isolates are of a single clone, 
which is represented by C. jejuni IA3902.
8
  In the guinea pigs of the study reported here, 
we identified several unique features of C. jejuni IA3902, when compared with those of a 
sheep commensal fecal isolate (C. jejuni OF48) and a fully sequenced human isolate (C. 
jejuni NCTC 11168). 
C. jejuni IA3902 was uniquely proficient in its ability to induce abortion. In the 
preliminary experiment with IP challenge exposure, which was intended to verify the 
abortifacient potential of this isolate, all of the pregnant guinea pigs aborted.  After oral 
inoculation, C. jejuni IA3902 was the only isolate that induced abortion (6/10 pregnant 
guinea pigs aborted).  Had the study been extended a few additional days, the abortion 
rate after oral inoculation would likely have been even higher with IA3902 because 
placentitis and fetal infection were identified in 1 guinea pig that had not yet aborted 
when the study was terminated.  This is in contrast to results of a study
17
 in which 4 
pathogenic human isolates of C. jejuni were evaluated in pregnant guinea pigs (abortion 
rates for those isolates ranged from 0% to 67% following IP inoculation and 0% 
following oral inoculation).  To our knowledge, the study reported here is the first to 
reveal that oral inoculation of C. jejuni can be effective in inducing abortion in pregnant 
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guinea pigs.  These results indicated that C. jejuni IA3902 was highly abortifacient and 
that pregnant guinea pigs were an effective method for evaluating the pathogenicity of 
this isolate for a natural route of infection (oral) or after IP inoculation. 
The pathogenesis of Campylobacter spp. that induce abortion when acquired by a 
nonvenereal route of transmission entails oral exposure, intestinal colonization, bacterial 
invasion, bacteremia, and infection of the fetoplacental unit.
1,21–23
  Sheep appear to be at 
increased risk for developing campylobacteriosis because healthy sheep often harbor 
Campylobacter spp. within the intestines and gall bladder.
1,24
  In a recent study,
25
 
Campylobacter spp. were identified in 49.5% of intestinal, gall bladder, and fecal 
samples obtained from healthy sheep.  The pathogenic mechanisms used by C. jejuni in 
the evasion of the physical and immunologic barriers in the intestine have been 
extensively studied and have been described elsewhere.
26,27
  In the study reported here, 
semiquantitative cultures of fecal samples revealed that all 3 strains of Campylobacter 
organisms were capable of colonizing the intestinal tract after oral administration, with C. 
jejuni IA3902 cultured in the greatest number of samples (10/12 [83%]) collected during 
necropsy, followed by C. jejuni NCTC 11168 (9/12 [75%]) and OF48 (6/12 [50%]). 
Once the intestines have been colonized, abortifacient Campylobacter spp. must 
breach the intestinal epithelium and induce bacteremia.  Bacteremia attributable to C. 
jejuni has been described,
28–30
 and results of 1 study
31
 indicated that certain strains of C. 
jejuni have an enhanced ability to induce bacteremia.  Because of the stress associated 
with blood collection and the limited blood volume that can be harvested from guinea 
pigs on a daily basis, the magnitude and duration of bacteremia was not directly assessed 
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in the present study, and an indirect gauge of systemic infection was used to estimate the 
incidence of bacteremia.  Acute hepatitis has been reported as a sequela to bacteremia 
attributable to C. jejuni in humans,
32
 and liver biopsy specimens from a patient with acute 
hepatitis and concurrent enteritis attributable to C. jejuni  revealed nonspecific reactive 
hepatitis with focal necrosis.
33
  Additionally, multifocal random hepatitis is a consistent 
necropsy finding secondary to bacteremia or septicemia for numerous organisms, 
including host-adapted Salmonella spp.
34
 such as Salmonella enterica serovar Dublin in 
cattle and Salmonella enterica serovar Choleraesuis in swine.  In the study reported here, 
the identification of multifocal, random hepatitis was used as indirect evidence of 
systemic infection.  This lesion was identified in 23 of 36 orally inoculated guinea pigs, 
including 11 of 12 guinea pigs inoculated with C. jejuni IA3902 and 8 of 12 guinea pigs 
inoculated with C. jejuni NCTC 11168.  The significantly higher rate of hepatitis in both 
groups indicated that each strain likely induced a degree of bacteremia, and it therefore 
seems likely that the differences in abortion rate were attributable to a mechanism other 
than the ability of these organisms to breach the intestinal epithelium and induce 
bacteremia. 
Predilection for the fetoplacental environment is a common attribute of 
abortifacient agents, and it appears that the greatest difference between C. jejuni IA3902 
and the other evaluated isolates was its affinity for the fetoplacental unit.  All 3 isolates 
were able to colonize the intestines, and there is evidence that both C. jejuni IA3902 and 
C. jejuni NCTC 11168 induced bacteremia after oral inoculation, yet only IA3902 
appeared to be able to colonize the placenta, infect trophoblasts, and induce abortion.  
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Guinea pigs inoculated with C. jejuni IA3902 consistently developed endometritis and 
placentitis with high numbers of C. jejuni (> 1,000 CFUs) recovered from uterine, 
placental, and pooled fetal tissues; all of which provided evidence for an apparent tropism 
of IA3902 for the fetoplacental unit. 
Analysis of our results indicated that immunohistochemical analysis was less 
sensitive than microbial culture as a means of detecting C. jejuni in tissues, which is 
consistent with results in other studies.
35,36
  However, immunohistochemical analysis was 
extremely useful in characterizing the distribution of organisms in placental tissues.  C. 
jejuni IA3902 appeared to localize at the periphery of the subplacenta near its junction 
with the main placenta early during the course of infection and was evident within both 
inflammatory cells and syncytiotrophoblasts of the subplacenta.  This localization 
appears logical because this is the site of placental vascular invasion
37
 and would be the 
first location reached during episodes of bacteremia.  Additionally, guinea pigs infected 
for longer periods before they aborted often had immunohistochemical evidence of 
abundant pericellular and intracytoplasmic organisms associated with the periarterial 
trophoblasts in the decidua.  These data suggested that trophoblasts of subplacental origin 
were preferentially infected, whereas those of the main placenta were spared.  It is worth 
mentioning that there are considerable differences between the placentation of guinea 
pigs and ewes.  Guinea pigs have a discoid, labyrinthine, hemochorial placenta with 
extensive trophoblast invasion of the decidua and uterine arterial walls.
38,39
  In contrast, 
sheep have a cotyledonary, epitheliochorial placenta and lack trophoblast invasion of 
uterine blood vessels.
39
  Although there are noticeable differences in placentation 
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between these 2 species, our immunohistochemical findings of organisms within 
trophoblasts, leukocytes, and perivascular tissues was consistent with that in another 
study
40
 of placentas from aborting sheep infected with C. jejuni.  Together, these findings 
suggest that pathogenic C. jejuni strains are capable of infecting trophoblasts regardless 
of placentation type, and this provides further supporting evidence for the appropriateness 
of the use of pregnant guinea pigs as a method for evaluation of Campylobacter-induced 
abortion.  To the authors’ knowledge, the information reported here is the first 
description of the localization and distribution of Campylobacter spp. within the placenta 
of aborting guinea pigs. 
In the study reported here, we determined that C. jejuni IA3902 was a unique, 
highly abortifacient strain with the ability to colonize the intestines, cause systemic 
infection, and induce abortion as a result of its affinity for the fetoplacental unit.  
Although we confirmed the highly pathogenic nature of IA3902 in pregnant guinea pigs, 
additional in vivo studies in sheep are required to determine the degree of virulence in 
pregnant ewes.  C. jejuni IA3902 appears to be a valuable strain for studying the 
pathogenesis of Campylobacter-induced abortion.  To facilitate the study of pathogenic 
mechanisms, the genome of IA3902 is being sequenced by our laboratory group, and we 
will compare it with a fully sequenced, nonabortifacient strain (NCTC 11168) to attempt 
to identify unique virulence traits of this abortifacient clone.  Results also revealed that 
pregnant guinea pigs are useful for studying the pathogenesis of abortion attributable to 
this unique Campylobacter strain.  Pregnant guinea pigs have been used to assess the 
efficacy of vaccines against C. fetus,
14–16
 and, given the recent shift from C. fetus to 
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predominantly C. jejuni causing abortions in sheep,
8
 there is an urgent need to explore the 
development of a vaccine against C. jejuni for the control of this emergent, highly 
pathogenic strain. 
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a. Elm Hill Labs, Chelmsford, MA. 
b. ATCC 700819, American Type Culture Collection, Manassas, VA. 
c. BBL CultureSwab, Becton-Dickinson Co, Franklin Lakes, NJ. 
d. Whirl-Pak bags, Nasco, Fort Atkinson, WI.  
e. Preston Campylobacter selective supplement, Oxoid Ltd, Cambridge, England. 
f. Campylobacter growth supplement, Oxoid Ltd, Cambridge, England. 
g. OptiMaxPlus, BioGenex, San Ramon, CA. 
h. MultiLink, BioGenex, San Ramon, CA. 
i. Zymed, Invitrogen, Carlsbad, CA. 
j. NovaRED, Vector, Burlingame, CA. 
k. Thermo Scientific, Pittsburgh, PA. 
l. SAS, version 9.1, SAS Institute Inc, Cary, NC. 
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Table 1.  Summary of strain-related differences in abortion rate and 
histopathologic lesions following oral inoculation with C. jejuni 
Inoculum Dose Aborted* 
Multifocal    
random hepatitis* 
Necrosuppurative 
placentitis* 
Mean uterine 
inflammatory score† 
 
Sham 
 
MH broth only 0/4 
 
0/5 
 
0/4 
 
0.5  0.4 
OF48 5.5 x 108 CFU 0/10 4/12 0/9‡ 0.4  0.3 
NCTC 11168 5.9 x 108 CFU 0/10 8/12 1/10 0  0.3 
IA3902 6.0 x 108 CFU 6/10 11/12 8/10 2.3  0.3 
 
*Represents the number of guinea pigs with this characteristic/number of guinea pigs inoculated.  †Score ranged from 0 
(inflammatory infiltrate not identified) to 3.5 (> 20 leukocytes/hpf and the inflammation extended into the underlying myometrium). 
‡One guinea pig gave birth before the end of the study and a placental sample was not obtained. 
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Table 2.  Sample source and semiquantitative recovery of C. jejuni cultured from 
samples obtained during necropsy of guinea pigs inoculated with IA3902 
 
 
Sample source 
No. of culture- 
positive samples* 
Low recovery    
(< 50 CFUs)† 
Moderate recovery 
(50 to 1,000 
CFUs)† 
High recovery        
(> 1,000 CFUs)† 
     
Blood 5/12 3/5 2/5 0/5 
Bile 2/12 0/2 1/2 1/2 
Feces 10/12 2/10 6/10 2/10 
Fetal stomach contents (pooled) 4/8‡ 2/4 1/4 1/4 
Gravid uterus 6/10 0/6 1/6 5/6 
Fetal liver or lung (pooled) 6/10 1/6 0/6 5/6 
Placenta 7/10 0/7 0/7 7/7 
 
*Values reported represent number of samples with positive culture results/number of samples tested.  †Results reported represent 
number of samples within that category/number of samples with positive culture results.  ‡Fetal stomach contents were only 
obtained for 8 of 10 pregnant guinea pigs.  Pooled = Samples for all fetuses of a specific guinea pig were pooled for microbial 
culture. 
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Figure 1.  Photomicrographs of sections of placental tissues obtained from guinea 
pigs inoculated with C. jejuni IA3902.  A—Notice the necrosuppurative placentitis and 
hemorrhage at the junctional zone (JZ) between the subplacenta (SP) and main placenta 
(MP) and marked vasculitis of the adjacent uteroplacental artery (UA) H&E stain; bar = 
200 M.  B—Photomicrograph of the same section of placental tissue in panel A after 
immunohistochemical staining for C. jejuni.  Notice the C. jejuni organisms (red stain) 
located within inflammatory cells and in extracellular spaces in the junctional zone. 
Primary antibody was directed against the major outer membrane protein of C. jejuni, 
followed by a biotinylated secondary antibody and incubation with horseradish 
peroxidase–streptavidin conjugate and developed by use of a commercial chromogen; 
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counterstained with Shandon Harris hematoxylin and Scott’s tap water; bar = 200 m. 
C—Photomicrograph of a section of guinea pig placental tissue after 
immunohistochemical staining for C. jejuni.  Notice the C. jejuni organisms (red stain) 
within the trophoblasts and syncytial streamers (SS) of the subplacenta.  Bar = 50 m. 
D—Photomicrograph of a uteroplacental artery (UA) from a guinea pig that aborted 8 
days after inoculation.  Notice the marked vasculitis and abundant perivascular C. jejuni 
organisms (red stain).  Immunohistochemical stain for C. jejuni; bar = 50 M. 
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Figure 2.  Percentage of samples with positive results when cultured for C. jejuni. 
Samples were obtained during necropsy of guinea pigs after oral inoculation with C. 
jejuni strain IA3902, NCTC 11168, or OF48 or a sham inoculum.  Necropsies were 
performed at the time of abortion or at 21 days after inoculation in guinea pigs that did 
not abort. 
 
68 
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Abstract 
Toll-like receptors (TLRs) 2 and 4 are well-characterized cell-surface receptors 
that recognize specific pathogen-associated molecular patterns and play an important role 
in pathogen recognition and activation of the innate immune system.  Variable expression 
of TLR2 and TLR4 has been described in trophoblasts from both normal and diseased 
placentas, yet there are limited data regarding trophoblast TLR expression in response to 
specific placental pathogens, and TLR expression in the guinea pig placenta has not been 
described.  The guinea pig is an effective model for Campylobacter-induced abortion of 
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small ruminants and we have previously shown by immunohistochemistry that 
Campylobacter jejuni localizes within syncytiotrophoblasts of the guinea pig subplacenta.  
The present study was designed to determine if the expression of either TLR2 or TLR4 
would be affected in subplacental trophoblasts following infection with C. jejuni.  
Immunohistochemistry for TLR2 and TLR4 was performed on placenta from guinea pigs 
that aborted following inoculation with C. jejuni and from sham-inoculated controls.  
Quantitative assessment of TLR expression was performed, and mean immunoreactivity 
for TLR2 was significantly higher in subplacental trophoblasts from animals that aborted 
compared with uninfected controls (P = 0.0283) whereas TLR4 expression was not 
statistically different (P = 0.5909).  These results suggest that abortion in guinea pigs 
following infection with C. jejuni is associated with increased TLR2 expression in 
subplacental trophoblasts and may reveal a possible role for TLR2 in the pathogenesis of 
Campylobacter-induced abortion. 
 
Introduction 
Campylobacter spp. are a frequent cause of ovine abortion worldwide,
1
 and a 
recent USDA:APHIS survey reported that campylobacteriosis was the most common 
cause of infectious abortion in US flocks.
2
  Historically, Campylobacter fetus subsp. fetus 
has been the major isolate from cases of ovine campylobacteriosis.
3
  However, two recent 
studies have shown a marked shift in this relationship with C. jejuni becoming the 
predominant isolate.
4,5
  Various molecular typing methods including pulsed-field gel 
electrophoresis have further demonstrated that a single tetracycline-resistant C. jejuni 
70 
 
clone (SA clone for Sheep Abortion) has emerged as the predominant cause associated 
with ovine abortions in Iowa, South Dakota, Idaho, California, Oregon, and Nevada.
5
  
Despite the relative frequency of campylobacteriosis, the exact mechanisms of 
Campylobacter-induced abortion in small ruminants are largely unknown, and the focus 
of the present study is to gain insight into potential mechanisms underlying the 
pathogenesis of this disease. 
Toll-like receptors (TLRs) are a well-characterized family of pattern recognition 
receptors (PRRs) that play a key role in innate immune function and have been 
extensively reviewed.
6-9
  In brief, there are currently 13 members of the TLR family that 
have been identified in mice,
6
 10 of which (TLRs 1-10) have also been identified in 
cattle, swine, sheep, and humans, and TLR genes have a high degree of sequence 
similarity between species.
10
  TLRs can be grouped based upon the characteristics of their 
ligands and on the location of cellular expression.  TLRs 1, 2, 4, 5 and 6 recognize 
specific pathogen-associated molecular patterns (PAMPs) such as triacyl lipopeptide 
(TLR1/TLR2), peptidoglycan (TLR2), lipopolysaccharide (TLR4), flagellin (TLR5), and 
diacyl lipopeptide (TLR6/TLR2), and are expressed on the cell surface; whereas TLRs 3, 
7, 8 and 9 recognize pathogen-associated nucleic acid patterns and are expressed in 
intracellular compartments such as endosomes.
6
  TLR2 recognizes the most diverse group 
of ligands and this is made possible, at least in part, by the formation of heterodimers 
with TLR1 and TLR6.
11
  Members of the TLR family are expressed by a variety of cell 
types including those directly involved in host immunity, such as macrophages, 
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neutrophils, and dendritic cells and non-immune cells such as fibroblasts, endothelial 
cells and various epithelial cells.
6
      
The maternofetal interface has long been considered an immunological paradox as 
the endometrium must allow for implantation of the allogenic placenta while maintaining 
adequate immune surveillance against a diverse spectrum of potential pathogens.
12
  The 
role of PRRs in this process, particularly TLRs, has been an active area of research and 
the subject of a recent review.
13
  Immunohistochemistry has been used to characterize the 
expression of TLR2 and TLR4 in the various trophoblast layers from both normal and 
diseased human placentas;
14-17
 however, there are limited data regarding trophoblast TLR 
expression associated with specific placental pathogens and TLR expression in the guinea 
pig placenta has not been described.  We have previously shown by IHC that C. jejuni 
localizes within junctional zone trophoblasts of the guinea pig subplacenta,
18
 and we 
hypothesize that expression of one or more TLRs will be increased in subplacental 
trophoblasts following infection with C. jejuni IA3902 (a clinical sheep abortion isolate 
belonging to the SA clone). 
Previous studies have revealed that TLR2 and TLR4, but not TLR5 are capable of 
binding PAMPs of Campylobacter spp.  More specifically, the flagellin of C. jejuni does 
not effectively bind TLR5,
19,20
 C. jejuni and C. coli induce IL-8 secretion by polarized 
human intestinal epithelial cells in a TLR-mediated manner,
21
 C. rectus infection 
increases TLR4 expression in murine placentas,
22
 C. jejuni surface polysaccharides 
induce IL-6 production in human intestinal epithelial cells via TLR2,
23
 and lysed C. 
jejuni effectively activates both chicken and human TLR2 and TLR4.
24
  Accordingly, in 
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the study reported here, IHC was used to evaluate the expression of TLR2 and TLR4 in 
guinea pig subplacental trophoblasts following infection with C. jejuni IA3902 in order to 
delineate the involvement of these TLRs in response to this specific placental pathogen.   
 
Materials and Methods 
Sample collection—Blocks of formalin-fixed, paraffin-embedded guinea pig 
placenta were obtained from animals used in previous experiments.
18
  In these 
experiments, animals were inoculated orally with C. jejuni IA3902 at approximately 4 
weeks of gestation with abortions occurring between 4 and 14 days post-inoculation.  
Aborted placentas (44 total) were obtained from 12 orally inoculated guinea pigs.  Pooled 
placental tissues from each of these dams were culture positive for C. jejuni indicating 
that at least one of the placental samples from each orally challenged guinea pig was 
infected.  Control placentas (28 total) were obtained from 9 sham-inoculated animals at 
21 days post-inoculation.   
Histologic evaluation—H&E stained sections of each placenta were evaluated to 
determine the presence or absence of suppurative placentitis as defined by the presence of 
infiltrating heterophils within the junctional zone between the subplacenta and decidua.    
Immunohistochemistry—Formalin-fixed, paraffin-embedded guinea pig 
placental samples were prepared for IHC as previously described.
18
  For antigen retrieval, 
sections were treated with 0.1% protease in a Tris buffer (pH, 7.6) at 37
o
C for 10 minutes 
followed by 3 rinses in PBS solution prior to placement in an automated cell staining 
system (BioGenex, USA).  Sections were then incubated in 10% neutral goat serum at 
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22
o
C for 20 minutes to inhibit nonspecific binding.  Primary antibodies consisted of 
commercially available, affinity purified rabbit-antihuman TLR2 (Rockland, USA) and 
affinity purified rabbit-antihuman TLR4 (Rockland, USA), and were used at dilutions of 
1:500 and 1:300, respectively.  Rabbit-antihuman TLR2 and TLR4 primary antibodies 
have been previously shown to be cross-reactive in guinea pig tissues.
25
  Slides were 
incubated at 22
o
C for 60 minutes (TLR2) or 120 minutes (TLR4) followed by rinsing in a 
bath of PBS solution for 5 minutes.  The secondary antibody (BioGenex, USA), horse 
radish peroxidase–streptavidin conjugate (Invitrogen, USA), chromogen (Vector, USA), 
and counterstaining steps were performed as previously described.
18
   Positive control 
samples consisted of guinea pig spleen and lung tissues for evaluation of receptor 
expression on phagocytes.  Negative controls were prepared from the same blocks and 
consisted of sections in which the primary antibody was omitted and sections in which 
normal (preimmune) rabbit serum was applied in place of the primary antibody.   
IHC for C. jejuni was also performed on all aborted placentas as previously 
described.
18
   
Image analysis—IHC-stained sections were examined with an Olympus BX60 
light microscope (Olympus, Japan) and RGB color digital images were recorded using an 
Olympus DP70 camera (Olympus, Japan) with 2040 x 1536 bit resolution and 24-bit 
depth.  Three 40X magnification images were obtained for each subplacenta and included 
one image taken from each lateral aspect of the junctional zone and one from the area just 
below the central excavation.  The recorded microscopic fields were oriented such that 
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subplacental trophoblasts filled as much of the field as possible while excluding any 
inflammatory exudate present in the junctional zone.   
To quantify the level of TLR protein expression in subplacental trophoblasts, all 
digital images were analyzed using ImageJ image analysis software (NIH, USA) and a 
colour deconvolution (stain separation) plug-in implementing methods previously 
described.
26
  Using the plug-in, the red color (positive immunohistochemical staining) 
was isolated in each image and then converted to a black and white image and set to a 
common threshold.  Thresholds of 175 and 200 were selected for TLR2 and TLR4, 
respectively.  The percent area of each image exhibiting the selected threshold level of 
staining was then quantified.  The mean percent stained area was then determined for the 
three images from each placenta, and the average staining of all placentas from each 
individual guinea pig was calculated and compared.   
Statistical analysis—A commercial statistical software package (SAS 9.2, SAS 
Institute, USA) was used to perform independent samples t-tests for a difference in mean 
TLR protein expression between groups.  Statistical significance was determined as P    
0.05. 
 
Results 
Histologic findings in affected placentas— Placentas from aborting guinea pigs 
were typically characterized by one or more of the following changes:  congestion of the 
placental labyrinth, multifocal necrosis of the placental disc, and multifocal to coalescing 
necrosis of subplacental trophoblasts (Figure 1) that was often associated with 
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heterophilic infiltration.  The placental junctional zone in at least one placenta from all 
(12/12) aborting guinea pigs was infiltrated with heterophils; however, not every placenta 
from each aborting animal was equally affected.  This was most notable in guinea pigs 
with higher fetal numbers, as would be expected, and occasionally placentas from 
individual fetuses lacked histologic lesions.  In total, 88.6% (39/44) of placentas from 
aborting guinea pigs had evidence of suppurative placentitis.  IHC for C. jejuni revealed 
that 65.9% (29/44) of placentas from these aborting animals had direct evidence of 
bacterial infection within subplacental trophoblasts and phagocytes in the placental 
junctional zone, and 100% (29/29) of IHC-positive placentas had suppurative placentitis.  
Placentas from sham-inoculated controls lacked significant lesions (Figure 2).  
Multifocally there were small areas in which subplacental trophoblasts appeared 
hypereosinophilic with pyknotic nuclei and often surrounded accumulations of scant to 
moderate amounts of eosinophilic cellular and karyorrhectic debris (necrosis) admixed 
with basophilic granular material (mineral); however, these areas were not associated 
with heterophilic infiltration and were generally limited to the lateral aspects of the 
junctional zone.     
Expression of TLR2—IHC of aborted placentas revealed a moderate increase in 
TLR2 immunoreactivity within trophoblasts of the main placenta as compared with 
controls; however, strong positive immunoreactivity was a consistent feature of 
subplacental syncytiotrophoblast cells and syncytial islands within lacunae, whereas the 
cytotrophoblast layer lacked significant staining (Figure 3).  In sham-inoculated control 
tissues, a low level of diffuse cytoplasmic immunoreactivity for TLR2 was evident in 
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trophoblasts of the interlobium of the main placenta, whereas the syncytiotrophoblast and 
cytotrophoblast cells of the subplacenta were generally unstained (Figure 4).  Positive 
immunoreactivity was also observed in heterophils and macrophages within control 
tissues while negative controls were nonreactive (not shown).   
Expression of TLR4—IHC of aborted placentas revealed moderate TLR4 
immunoreactivity within trophoblasts of the main placenta and in the mesenchyme and 
surrounding vascular spaces of subplacental lamellae.  A low level of positive 
immunoreactivity was an inconsistent feature of subplacental syncytiotrophoblast cells, 
while the adjacent cytotrophoblast layer lacked significant staining (Figure 5).  IHC of 
sham-inoculated control tissues revealed scant cytoplasmic immunoreactivity for TLR4 
in trophoblasts of the interlobium, moderate immunoreactivity within the mesenchyme 
and surrounding vascular spaces in subplacental lamellae, and minimal to no 
immunoreactivity within subplacental syncytiotrophoblast and cytotrophoblast cells 
(Figure 6).  Strong positive immunoreactivity was also observed in heterophils and 
macrophages within control tissues while negative controls were nonreactive (not 
shown).   
Image analysis of subplacental immunoreactivity—TLR2 immunoreactivity 
was significantly higher in subplacental trophoblasts from aborted placentas compared 
with non-aborted, sham-inoculated controls (P = 0.0283).  The mean percent area 
corresponding to positive immunohistochemical staining for images obtained from each 
group are summarized (Figure 7).  This difference was even more significant when 
comparing mean TLR2 immunoreactivity between controls and only those placentas with 
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suppurative placentitis and positive IHC for C. jejuni (P = 0.0108), whereas mean 
immunoreactivity of placentas with evidence suppurative placentitis but IHC-negative for 
C. jejuni and those aborted placentas that lacked placentitis did not differ significantly 
from controls (P = 0.7350 and P = 0.0724, respectively).  These results are summarized 
in Figure 8.   
TLR4 immunoreactivity did not differ significantly between aborted placentas 
and controls (P = 0.5909).  The mean percent area corresponding to positive 
immunohistochemical staining for images obtained from each group are summarized 
(Figure 7).  Additionally, mean TLR4 immunoreactivity did not differ significantly when 
comparing control placentas with only those placentas from aborting animals that had 
suppurative placentitis and positive IHC for C. jejuni (P = 0.9830), those with only 
suppurative placentitis (P = 0.9321), or only those placentas from aborting guinea pigs 
that lacked placentitis (P = 0.2380).  These results are summarized in Figure 8.   
 
Discussion 
Campylobacteriosis is a well-recognized cause of small ruminant abortion 
worldwide; however, the exact molecular mechanisms involved in this process are not 
known.  We have recently shown using IHC that, following oral inoculation, C. jejuni 
IA3902 localizes within syncytiotrophoblast cells of the guinea pig subplacenta,
18
 and in 
the present study, 65.9% (29/44) of placentas from infected guinea pigs had evidence of 
C. jejuni antigen by IHC, consistent with the 71.4% noted in our previous work.  To 
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further explore potential mechanisms associated with Campylobacter-induced abortion, 
IHC for TLR2 and TLR4 was performed on these placental tissues.  
The guinea pig placenta consists of a disc-like, labyrinthine chorioallantoic main 
placenta with separate subplacenta and yolk sac placenta.
27
  The subplacenta is unique to 
hystricognath rodents and its histological, histochemical and ultrastructural properties 
have been thoroughly described elsewhere.
28-30
  In brief, the subplacenta is separated 
from the main placenta by a thin layer of fetal mesenchyme,
31
 and the distal segments of 
the uteroplacental arteries enter the main placenta through the periphery of this 
junction.
28
  It is in this location that we consistently observe C. jejuni via IHC which 
seems logical as this is the site of placental vascular invasion and would be the first 
location reached during episodes of bacteremia.  The subplacenta is composed of 
lamellae of mesenchyme which support a folded layer of cytotrophoblast cells that give 
rise to a syncytiotrophoblast layer along the decidual surface.
28
  As gestation progresses, 
syncytiotrophoblasts form extensive lacunae that contain abundant eosinophilic material 
and syncytial islands.
28
  The interface between the subplacenta and decidua is known as 
the junctional zone,
28
 and our current and previous immunohistochemical findings 
indicate that, in pregnant guinea pigs, C. jejuni IA3902 localizes within subplacental 
trophoblasts at the periphery of this junctional zone near the site of placental vascular 
invasion, while the main placenta is spared.  For this reason, we focused our efforts in the 
present study on TLR expression within subplacental trophoblasts.     
In the study reported here, we observed markedly increased immunoreactivity for 
TLR2 protein in the syncytiotrophoblast layer of the subplacenta from guinea pigs 
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aborting following infection with C. jejuni versus sham-inoculated controls.  This 
occurred without significant change in the underlying cytotrophoblast cells, and this is 
significant as the syncytiotrophoblast constitutes the frontal barrier of the placenta at the 
maternofetal interface.  As the guinea pig generally has multiple offspring in each litter, it 
is likely that during any bacteremic event there may be an uneven distribution of 
organisms seeding fetoplacental units.  As such, we further subdivided the placentas from 
aborting guinea pigs based upon the presence of positive IHC for C. jejuni, the presence 
placentitis without IHC for C. jejuni, and the absence of placentitis.  Previous studies 
have shown that IHC is less sensitive than culture in detecting Campylobacter spp. within 
placental tissues,
18,32
 thus it is possible that all inflamed placentas were infected with C. 
jejuni, but that campylobacter numbers in IHC-negative inflamed placentas were 
substantially lower than IHC-positive placentas.  Within the subdivided groups, placentas 
with placentitis and positive IHC for C. jejuni had significantly greater levels of TLR2 
immunoreactivity when compared with controls, while the placentas from aborting 
animals that were inflamed but IHC-negative or that lacked placentitis did not differ from 
controls.  These findings are intriguing and suggest an association between the presence 
of C. jejuni and increased expression of TLR2.  While these results do not give 
information with regard to the exact mechanism of increased TLR2 expression, the 
presence of increased TLR2 protein suggests a potential role in the disease pathogenesis.  
A recent study in human intestinal epithelial cells has shown that C. jejuni surface 
polysaccharides induce IL-6 production via TLR2,
23
 and studies in first trimester human 
trophoblasts have revealed that TLR2 ligation induces increased production of IL-6 and 
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IL-8 as well as increased trophoblast apoptosis.
33
  The combined presence of suppurative 
placentitis and increased TLR2 expression in the infected tissues of this report is 
consistent with this type of pro-inflammatory response; however, further studies are 
required to determine if the increased expression of TLR2 is a direct effect of the 
organism or a downstream effect of placental inflammation, and to elucidate the exact 
cytokine response that occurs in guinea pig trophoblasts in response to C. jejuni.    
In contrast to our findings with TLR2, TLR4 protein expression in subplacental 
trophoblasts did not differ significantly between controls and placentas from aborting 
animals overall or from any of the subdivided groups.  These results suggest that altered 
TLR4 expression is not associated with Campylobacter-induced abortion in guinea pigs.  
While these results appear to conflict with the findings of increased TLR4 in murine 
placentas exposed to Campylobacter rectus,
22
 it is worth noting that there are significant 
differences between the two studies.  First, unlike caviomorphs, mice lack a subplacenta
34
 
and TLR4 IHC in the study by Arce, et al. (2009) assessed expression in trophoblasts 
from the placental labyrinth.  Second, abortion was not the endpoint of the murine study
22
 
so the level of TLR4 expression at the point of pregnancy termination was not assessed.  
Additionally, challenge with C. rectus in the murine study was designed to assess the 
placental response to chronic oral exposure to a periodontal pathogen, whereas the 
present study assessed the placental response to acute infection with a highly 
abortifacient C. jejuni strain.  Finally, Arce, et al. (2009) only evaluated TLR4 so it 
remains to be seen what, if any, TLR2 response might occur in murine placentas 
following infection with C. rectus.  It is also conceivable that both receptors may be 
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elevated at some point throughout the disease process as time-dependent interdependence 
between TLR4 and TLR2 has also been described.
35
 
Limitations of this study include its retrospective nature and the lack of specific 
time matched control placentas for each aborted placenta.  The presence of non-inflamed 
placentas within the pool of aborted tissues did, however, serve as an internal control, 
and, considering that the immunoreactivity of these tissues was similar to sham-
inoculated control tissues, it appears that the constitutive expression of TLR2 and TLR4 
in the guinea pig subplacenta does not vary significantly throughout the period studied.  
Additionally, the relevance of these findings to ovine campylobacteriosis is uncertain; 
however, a recent study of obesity induced placental inflammation in ewes revealed 
elevated mRNA expression for both TLR2 and TLR4 with a concurrent increase in 
proinflammatory cytokines,
36
 and these results support a role for TLRs in the response of 
ovine placenta to inflammatory stimuli.   
In summary, we observed increased TLR2 immunoreactivity in subplacental 
syncytiotrophoblast cells from guinea pigs aborting following oral inoculation with C. 
jejuni while TLR4 immunoreactivity was essentially unchanged, and that these changes 
were most prominent in syncytiotrophoblasts from placentas with direct evidence of C. 
jejuni by IHC.  Identification of these changes in subplacental syncytiotrophoblast cells is 
significant as these cells form the frontal barrier at the maternofetal interface and 
therefore suggest a role for TLRs in bacterial sensing and the subsequent inflammatory 
response generated during septic abortion due to C. jejuni.  To our knowledge, this is the 
first report of TLR expression in the guinea pig placenta and the first report to describe 
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trophoblast TLR expression associated with a specific, well-documented placental 
pathogen.  These findings warrant further investigation to determine the exact role of 
TLR2 expression in the pathogenesis of C. jejuni-associated abortion.   
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Figure 1.  Placenta; guinea pig infected with C. jejuni IA3902.  The placental labyrinth 
(PL) is markedly congested and the subplacental lamellae (*) are undergoing 
degeneration and necrosis and beginning to separate from the main placenta.  The central 
excavation (CE) is to the right.  HE. 
Figure 2.  Placenta; guinea pig, sham-inoculated control.  The placental labyrinth 
(PL), central excavation (CE), subplacental lamellae, and extensive lacunae (+) appear 
normal.  HE.   
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Figure 3.  Subplacenta; guinea pig infected with C. jejuni IA3902; IHC for TLR2.  
Note the strong immunoreactivity of syncytiotrophoblasts (arrows) and syncytial islands 
within lacunae (arrowheads), while the subjacent cytotrophoblast layer and mesenchyme 
are relatively unstained (asterisks).  NovaRED substrate and Mayer’s hematoxylin 
counterstain.   
Figure 4.  Subplacenta; guinea pig, sham-inoculated control; IHC for TLR2.  Note 
the overall lack of immunoreactivity compared with Figure 3, particularly within the 
syncytiotrophoblast cells lining the subplacental lamellae (arrows) and syncytial islands 
within lacunae (arrowheads).  The subjacent cytotrophoblast layer and mesenchyme are 
also unstained (asterisks).  NovaRED substrate and Mayer’s hematoxylin counterstain.   
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Figure 5.  Subplacenta; guinea pig infected with C. jejuni IA3902; IHC for TLR4.  
Note the low level of specific immunoreactivity overall, with the strongest staining 
within the mesenchyme and surrounding vascular spaces within subplacental lamellae 
(asterisks).  Syncytiotrophoblast cells (arrows) and syncytial islands (arrowheads) are 
unstained.  NovaRED substrate and Mayer’s hematoxylin counterstain.   
Figure 6.  Subplacenta; guinea pig, sham-inoculated control; IHC for TLR4.  Note 
the low level of immunoreactivity overall, with moderate staining within the 
mesenchyme of subplacental lamellae (asterisks).  Syncytiotrophoblasts (arrows) and 
syncytial islands (arrowheads) are unstained.  NovaRED substrate and Mayer’s 
hematoxylin counterstain.   
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Figure 7.  Percent area of subplacental photomicrographs corresponding to positive 
staining for TLR2 or TLR4 per 40X field (mean ± SEM).  Values represent mean 
immunoreactivity for all placentas from aborting guinea pigs (n=12; 44 placentas total) 
and non-aborted controls (n=9; 28 placentas total).  * = Values differ significantly (P = 
0.0283).  
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Figure 8.  Percent area of subplacental photomicrographs corresponding to positive 
staining for TLR2 or TLR4 per 40X field (mean ± SEM).  Values represent mean 
immunoreactivity for all aborted placentas IHC+ for C. jejuni (n=9; 30 placentas total), 
aborted placentas with placentitis but IHC- for C. jejuni (n=5; 9 placentas total), aborted 
placentas without placentitis (n=3; 5 placentas total) and non-aborted controls (n=9; 28 
placentas total).  * = Value differs significantly from controls (P = 0.0108).  
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Abstract 
Objective—To compare efficacy of two commercial ovine Campylobacter 
vaccines and an experimental bacterin in guinea pigs following IP inoculation with C. 
jejuni IA3902.   
Animals—51 female Hartley guinea pigs. 
Procedures—Pregnant and non-pregnant animals were randomly assigned to 1 of 
4 treatment groups and administered 2 subcutaneous doses 14 days apart of commercial 
vaccine A (n = 13), commercial vaccine B (n = 12), an experimental bacterin prepared 
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from the challenge strain (n = 12), or a sham vaccine (n = 14).  10 days later, animals 
were challenged IP with C. jejuni IA3902.  48 hours post-challenge, animals were 
euthanized, a complete necropsy was performed, and blood and tissue samples were 
obtained for culture.      
Results—Administration of vaccine B or the experimental bacterin significantly 
reduced 48 hour infection rates versus sham-vaccinated controls (P < 0.001 and P = 
0.0162, respectively), whereas those administered vaccine A did not differ from controls 
(P > 0.999).  A significantly reduced 48 hour infection rate was associated with 
administration of vaccine B independent of pregnancy status.    
Conclusions and Clinical Relevance—Administration of vaccine B significantly 
reduced infection in guinea pigs challenged with C. jejuni IA3902 similar to a 
homologous bacterin.  These results suggest vaccine B or an autogenous product may be 
effective in controlling ovine campylobacteriosis due to this emergent abortifacient 
strain.  Additionally, culturing blood, liver, bile and uterus in non-pregnant guinea pigs 
48 hours post-inoculation may be a useful screening tool for comparing efficacy of C. 
jejuni vaccines. 
 
Introduction 
Campylobacter spp. are a well-recognized and notable cause of ovine abortion 
worldwide with abortion rates of 5-50% reported in affected flocks.
1
  A recent national 
survey ranked campylobacteriosis first among infectious causes of abortion in domestic 
sheep.
2
  Two recent studies
3,4
 have demonstrated that Campylobacter jejuni is the 
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predominant species responsible for Campylobacter-associated sheep abortion in the 
United States, and molecular typing techniques have further revealed that within these C. 
jejuni a single tetracycline-resistant clone (named SA clone for Sheep Abortion) has 
emerged as the predominant cause of ovine abortion in Iowa, South Dakota, Idaho, 
California, Oregon, and Nevada.
4
  This new, emerging clone is significant in that 
Campylobacter spp. isolated from ovine abortions in different regions and during 
different lambing seasons traditionally exhibit marked genetic and antigenic 
heterogeneity.
3,5-9
   
The effectiveness of vaccination for the prevention of ovine campylobacteriosis 
has been well-documented;
10-14
 however, experimental studies have also revealed 
inadequate protection to homologous challenge in ewes vaccinated with commercial 
vaccines of questionable efficacy
15
 and have demonstrated inadequate cross protection in 
those vaccinated and later challenged with heterologous serotypes.
12
  Additionally, 
Campylobacter spp. abortions have been reported in field cases from flocks receiving 
commercial monovalent
16
 and bivalent
3
 vaccines.  Accordingly, no single vaccine will 
likely be protective against all abortifacient Campylobacter spp., and continual efficacy 
testing is imperative to ensure the ongoing usefulness of a given vaccine.  The pregnant 
guinea pig is an effective model for screening abortifacient Campylobacter spp.,
17-19
 and 
has been described for testing the efficacy of commercial Campylobacter vaccines 
intended for cattle
20,21
 and sheep,
21
 as well as experimental bacterins.
22,23
  These efficacy 
studies have further demonstrated that immunization with a monovalent bacterin of either 
Campylobacter fetus subsp. fetus or C. jejuni is not cross protective against challenge 
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with the opposite species,
23
 and that protection is lower when challenged with a 
heterologous strain of the same species.
22,23
  These findings strongly support the need for 
polyvalent vaccines in the prevention of ovine campylobacteriosis. 
In the United States, there are currently two commercially available, ovine-
labeled polyvalent Campylobacter vaccines,
a,b 
each containing both C. fetus subsp. fetus 
and C. jejuni strains.  Given the emergence of C. jejuni clone SA as the predominant 
Campylobacter sp. recovered from sheep abortions across multiple states,
4
 we 
hypothesize that one or both of these vaccines may not be protective against this highly-
abortifacient strain.  Previous studies have assessed the prevention of abortion in 
pregnant guinea pigs following IP challenge as the evaluation endpoint for 
Campylobacter vaccine efficacy;
20-23
 however, given the increased cost associated with 
acquisition of pregnant animals and the housing costs associated with a multi-week 
observational study, we sought to determine if a mixed population of pregnant and non-
pregnant females would be an adequate, cost-effective model for screening 
Campylobacter vaccines.  As bacteremia is a requisite step in the pathogenesis of non-
venereal Campylobacter-induced abortion,
24
 the presence of blood and tissue infection in 
non-pregnant animals should provide an indication of the potential for abortion.  In our 
previous work,
19
 we observed abortions in pregnant guinea pigs as early as 48 hours 
following IP inoculation with C. jejuni IA3902 (a clinical abortion isolate belonging to 
the SA clone), and organisms were recoverable from the blood, bile, uterus and 
fetoplacental units at that time.  Accordingly, in the study reported here, blood and tissue 
colonization at 48 hours was selected as the evaluation endpoint to assess the efficacy of 
95 
 
two commercially available ovine campylobacteriosis vaccines and an experimental 
homologous bacterin in eliminating infection following IP challenge with C. jejuni 
IA3902 in both pregnant and non-pregnant guinea pigs.    
 
Materials and Methods 
Humane animal care and use – All procedures described herein were approved 
by the Institutional Animal Care and Use Committee (IACUC) at Iowa State University, 
Ames, IA. 
Animals – 51 female Hartley guinea pigs with an average weight of 879 g were 
obtained from a commercial source.
c
  All animals were recently bred but pregnancy could 
not be guaranteed for animals purchased at this stage of gestation.  Upon arrival, a rectal 
swab was obtained from each guinea pig, placed in transfer medium, and plated for 
Campylobacter culture as described below.  Guinea pigs were randomly assigned into 
four treatment groups (n = 14, n = 13, n = 12, n = 12), housed in individual cages with 
wood chip bedding, and fed a commercial pelleted guinea pig diet ad libitum.  Each 
guinea pig received the first subcutaneous dose of their respective vaccine treatment 
within 24 hours of arrival, and received a second subcutaneous dose 14 days later.  Ten 
days after receiving the second vaccination, guinea pigs were challenged IP with C. jejuni 
IA3902. 
Pregnancy determination – Abdominal palpation was performed to screen for 
pregnancy approximately 14 days after arrival.  Pregnancy status was confirmed by 
abdominal ultrasound 2 to 5 days prior to inoculation.      
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Vaccines – Vaccine Aa was a commercial, polyvalent product labeled for 
prevention of campylobacteriosis in sheep via two 5 ml subcutaneous doses.  For the 
purposes of the present study, the dose was reduced to 1 ml and administered 
subcutaneously in the interscapular region.  Vaccine B
b
 was a commercial, polyvalent 
product labeled for prevention of ovine campylobacteriosis via two 2 ml subcutaneous 
doses.  To keep the effective dose the same as that used for Vaccine A (20% of the 
labeled dose), the dose was reduced to 0.4 ml and administered subcutaneously in the 
interscapular region.  The commercial products each contained both C. fetus subsp. fetus 
and C. jejuni strains in an aluminum hydroxide adjuvant.  Accordingly, aluminum 
hydroxide gel
d
 was used in preparing the homologous bacterin for this experiment.  For 
preparation of the bacterin, a frozen stock of C. jejuni IA3902 was grown 
microaerobically on Mueller-Hinton (MH) agar for 48 hours at 42ºC, then subpassaged 
on MH agar for an additional 24 hours at 42ºC under the same atmospheric conditions.  
Lawns of C. jejuni were harvested in phosphate buffered saline (PBS) directly from 
plates by washing and then pelleted by centrifugation (15 min at 7,000g).  The pellet was 
then washed and resuspended in 10 ml of PBS containing 0.3% formalin.  This 
suspension was centrifuged again (30 min at 7,000g), the supernatant discarded, and the 
wash process repeated two additional times.  The final pellet was weighed and 
resuspended in sterile PBS to achieve a final concentration of 5 mg of C. jejuni cells per 
ml.  This final concentration was selected based upon a previous report
22
 comparing 
antigen dose and various adjuvant types in which this concentration provided 93% 
protection against homologous challenge.  A few drops of the diluted cells were streaked 
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on MH agar or added to enrichment broth, both of which were then placed in a 
microaerophilic environment to check efficacy of formalin killing.  Once killing was 
verified, sterile aluminum hydroxide gel was added to the diluted cell suspension to 
achieve a final concentration of 0.2 mg Al(OH)3/ml.  Higher concentrations of aluminum 
hydroxide adjuvant have been used in previous Campylobacter vaccine studies;
15,23
 
however, lower concentrations have been reported to be effective with experimental 
Bordetella
25
 and Salmonella
26
 vaccines and a lower concentration was therefore selected 
to decrease the risk of adverse reactions.  A hemacytometer was used to quantify the 
number of particles per ml for each preparation.  The approximate concentrations for the 
three preparations were 6.29 X 10
7
 per ml for vaccine A, 5.03 X 10
8
 per ml for vaccine B, 
and 8.83 X 10
7
 particles per ml for the experimental bacterin.  The roughly ten-fold 
higher concentration of particles per ml in vaccine B was further support for its 
administration at a reduced dose compared with the other treatments.  The experimental 
bacterin was administered as a 1 ml subcutaneous dose in the interscapular region.  A 
sham vaccine was prepared containing 0.2 mg/ml of aluminum hydroxide in sterile PBS 
and was administered as a 1 ml subcutaneous dose in the interscapular region.   
Challenge-exposure inocula – Fresh bacterial cultures of C. jejuni IA3902 were 
obtained following 24 hours of growth on MH agar in anaerobic jars under microaerobic 
conditions (5% O2, 10% CO2, 85% N2) at 42ºC.  These cultures were collected in MH 
broth, diluted to desired concentrations based on optical density (OD600) to give 
approximately 1 X 10
6
 CFU/ml, and then used as inocula in the challenge experiments.  
The final number of organisms in each suspension was determined by viable colony-
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forming unit (CFU) counting.  From our extensive experience in the laboratory, we 
expect that 24-hour grown (mid-logarithmic phase) C. jejuni cultures would yield 
approximately 1 X 10
7
 CFU/ml when adjusted to OD600:0.1.  
Animal inoculation – 10 days after receiving their second vaccination, all 
animals were inoculated IP with 1 ml of 7.5 X 10
5
 to 1.0 X 10
6
 CFU/ml MH broth culture 
of C. jejuni IA3902.  This concentration was chosen based upon results from our previous 
work,
19
 and a report
23
 describing IP challenge with C. jejuni in vaccinated pregnant 
guinea pigs.  
Monitoring, euthanasia and necropsy sampling – Once inoculated, guinea pigs 
were observed at least twice daily for signs of abortion or impending abortion.  These 
signs include vaginal bleeding, presence of expelled fetuses or visible fetal membranes.  
All animals were euthanized 48hours post-inoculation via IP injection of sodium 
pentobarbital (approximately 150 mg/kg) and necropsied immediately.  At necropsy, 
animals were inspected for gross lesions and samples were taken for bacterial culture, 
serology and histopathology.  Samples harvested for Campylobacter isolation included 
heart blood, liver, bile, uterus, and all placental units.  Samples of liver, gallbladder, 
uterus and placenta were taken for histopathology and placed in 10% neutral buffered 
formalin for 24 hours prior to paraffin embedding and routine processing for hematoxylin 
and eosin (H&E) staining. 
Isolation and semi-quantitative enumeration of C. jejuni from necropsy 
samples – Heart blood and bile were collected and transported using sterile needles and 
syringes.  Liver, uterus, and placenta were placed in separate sterile Petri plates for 
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transport prior to culture.  All samples were kept refrigerated until immediately prior to 
culture and were cultured on the day of collection.  Fluid samples (blood and bile) were 
placed directly onto culture media and streaked using sterile cotton swabs.  Tissue 
samples (liver, uterus, placenta) were minced with a scalpel/scissors, swabbed with a 
sterile cotton swab, and streaked onto the culture media.  All samples were spread onto 
MH agar containing a Campylobacter selective supplement
e
 (polymyxin B, rifampicin, 
trimethoprim and cycloheximide) and a Campylobacter growth supplement
f
 (sodium 
pyruvate, sodium metabisulphite, and ferrous sulphate) and were incubated for 48 hours 
in anaerobic jars under microaerobic conditions at 42ºC.  Following incubation, 
Campylobacter-like colonies on each plate were counted to determine the CFUs in each 
sample.  
Enzyme-linked immunosorbent assay (ELISA) – ELISA was used to determine 
the level of C. jejuni-specific IgG antibodies in guinea pig sera.  Microtiter plates
g
 were 
first coated with 100 l of whole membrane components (approx. 60 ng/well) of C. jejuni 
IA3902 in coating buffer (sodium carbonate; pH 9.6) overnight at 25ºC.  Then, plates 
were incubated with a blocking buffer (PBS containing 2 % milk, 2 % bovine serum 
albumin, and 0.1 % Tween-20) at 37C for 1 hr.  Serum samples were diluted in the 
blocking buffer to 1:100, and then 100 l of each dilution was added to individual wells.  
Duplicate wells were used for each sample.  After incubation at 25
o
C for 2 hr, the plates 
were washed 3 times with the wash buffer (PBS containing 0.1% Tween-20).  Polyclonal, 
horseradish peroxidase (HRP) labeled goat-anti-guinea pig IgG
h
 was diluted to 1:1000 in 
the blocking buffer and added to the wells (100 l/well).  After 2 hr incubation at 25oC, 
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the plates were washed three times with the wash buffer before the HRP substrate
i 
was 
added.  OD values of individual wells were measured using an ELISA reader
j
 at 405 nm.  
 Statistical analysis – A commercial statistical software packagek was used to 
perform all analyses.  Fisher’s exact test for binomial variables was employed when 
comparing the presence or absence of positive Campylobacter culture from samples of 
blood, liver, bile, uterus and placenta.  A 1-way ANOVA was used to detect differences 
in ELISA results obtained from sera and P values are reported after Tukey adjustment for 
multiple comparisons.      
 
Results 
Campylobacter spp. were not isolated from any of the pre-challenge rectal swabs.  
One sham-vaccinated guinea pig aborted approximately 36 hours post-inoculation with 
C. jejuni IA3902 and was euthanized and necropsied immediately.  All remaining guinea 
pigs were euthanized 48 hours post-inoculation at which time clinical signs of impending 
abortion were not observed.     
Gross lesions – At necropsy, gross lesions were limited to the liver and consisted 
of random, pinpoint to 2 mm diameter white foci scattered throughout the parenchyma.  
These lesions were noted in 10/14 sham-vaccinated animals, 11/13 animals receiving 
vaccine A, 2/12 animals receiving vaccine B, and 2/12 animals receiving the 
experimental bacterin.   
Histologic lesions – Suppurative placentitis was detected in the junctional zone 
between the subplacenta and decidua in all but one placental sample with positive culture 
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results for C. jejuni (7/8) and in no culture negative placental samples (0/11).  
Additionally, multifocal hemorrhage was present in the junctional zone of some affected 
placentas.  Random multifocal suppurative hepatitis was a consistent finding in animals 
receiving a sham vaccination or vaccine A.  Lesions were most frequent and of the 
greatest severity in the group receiving vaccine A.  Rare, small suppurative infiltrates 
were observed in a few animals receiving vaccine B or the experimental bacterin.   
Campylobacter culture – C. jejuni was recovered from at least one sample 
(blood, bile, liver, uterus or placenta) in 26 of 51 animals.  Of these 26 animals, 8 were 
pregnant and 18 were non-pregnant.  The frequency of positive blood and tissue cultures 
are summarized by treatment group and by pregnancy status within treatment groups in 
Table 1.  When compared with controls, animals receiving vaccine B had significantly 
lower recovery of Campylobacter from blood (P = 0.0171), bile (P = 0.0171), liver (P = 
0.0017), uterus (P = 0.0425), and placenta (P = 0.0476).  Animals receiving the 
homologous bacterin had significantly lower recovery from the liver and bile (P = 0.0472 
and 0.0171, respectively) versus controls.  Recovery rates for animals receiving vaccine 
A did not differ from controls (P > 0.25, all samples).  When comparing treatment groups 
by pregnancy status, the distribution of recovery rates was similar to that observed in 
each group overall; however, statistical significance was often not maintained given the 
small number of samples in certain subsets.    
For all animals with demonstrable tissue infection, the quantity of Campylobacter 
recovered from each sample type is summarized in Table 2.  Overall, Campylobacter was 
recovered in the highest numbers from the placenta of pregnant animals (8/8 with > 1000 
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CFUs) and bile of non-pregnant animals (11/18 with > 1000 CFUs).  While the recovery 
rates were generally low (< 50 CFUs), the majority of infected animals (23/26) had 
positive liver culture independent of pregnancy status.  For all samples except bile, 
organisms were recovered in greater quantity from pregnant animals.     
ELISA results – Vaccine A, vaccine B and the experimental bacterin each 
induced a significant level of Campylobacter-specific antibody relative to sham 
vaccination (P < 0.0001, P = 0.0033, and P < 0.0001, respectively).  The mean OD 
values for each group are summarized in Figure 1.  The mean OD for vaccine A and the 
experimental bacterin did not differ significantly (P = 0.7961); however, the mean OD 
for vaccine B was significantly lower than both the experimental bacterin and vaccine A 
(P = 0.0058 and P = 0.0408, respectively). 
Vaccine efficacy (elimination of detectable infection) – An animal was 
considered to have eliminated infection at 48 hours if all tested tissues were culture-
negative for Campylobacter.  The percentage of animals from each treatment group in 
which infection was eliminated is summarized in Figure 2.  Vaccine B yielded the highest 
overall percentage with 11/12 eliminating infection, and this differed significantly (P = 
0.000479) from sham-vaccinated controls where only 3/14 were culture-negative for 
Campylobacter.  A significantly greater percent free of infection was observed with 
vaccine B when comparing the subgroups of pregnant (P = 0.0333) or non-pregnant (P = 
0.0256) animals as well.  The overall clearance rate for animals receiving the 
homologous bacterin was 9/12 which differed significantly from controls (P = 0.0162); 
however, this significance was not maintained when comparing pregnant (P = 0.1667) or 
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non-pregnant (P = 0.1058) animals separately.  There was no significant difference in the 
elimination percentage overall or by pregnancy status when comparing animals receiving 
vaccine A versus sham-vaccinated controls (P > 0.999 for all tests).   
 
Discussion 
Comparative vaccine efficacy studies against emergent pathogens and novel 
pathogen strains are vital for veterinary practitioners and producers to help guide product 
selection during the development of disease management strategies.  Unfortunately, the 
cost and logistics of rapidly assessing vaccine efficacy in the target species is often 
prohibitive.  Ideally, Campylobacter vaccine efficacy studies would be undertaken in 
sheep; however, high seroprevalence for Campylobacter spp., the high carriage rate of 
Campylobacter spp. in the intestine and bile of healthy sheep,
27,28
 the high cost of 
Campylobacter-negative SPF sheep, and a lengthy gestation are significant impediments 
to the assessment of multiple vaccine treatments in pregnant ewes.  The goals of the 
present study were to design and evaluate a more manageable model for screening 
Campylobacter vaccines, and to employ this model in the assessment of the potential 
efficacy of 2 commercially available ovine-labeled Campylobacter vaccines
a,b
 against an 
emergent C. jejuni strain.   
The small size, reduced housing costs, and ease of obtaining Campylobacter-
negative animals make guinea pigs a desirable model for evaluating the efficacy of 
Campylobacter vaccines.  In previous studies,
20-23
 the prevention of abortion in pregnant 
guinea pigs following IP challenge has been the evaluation endpoint; however, if animals 
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are to receive two doses of vaccine prior to inoculation, they need to be purchased at a 
time point prior to that at which pregnancy can be confirmed, or a large breeding colony 
needs to be established.  In either situation, it is unlikely that 100% of vaccinated animals 
will be pregnant or will successfully become pregnant and would therefore be unusable if 
abortion is the sole evaluation endpoint.  Additionally, the lengthy post-inoculation 
observation period (up to 21 days) and any unused non-pregnant animals further inflate 
the overall cost of previously described model systems.  We have shown that pregnant 
guinea pigs are highly susceptible to C. jejuni IA3902,
19
 and that high numbers of 
organisms are potentially recoverable from blood and other non-reproductive tissues 
(liver and bile) in addition to fetoplacental units as early as 48 hours post-inoculation.  
Thus, the present study was designed to evaluate the utility of a mixed population of both 
pregnant and non-pregnant guinea pigs in screening for Campylobacter vaccine efficacy, 
a process that has not previously been described.    
In contrast to venereally acquired campylobacteriosis in cattle, sheep are more 
likely to acquire Campylobacter spp. organisms by the oral route with subsequent 
bacteremia and seeding of fetoplacental units by abortifacient strains.  As such, resolution 
of bacteremia following intraperitoneal challenge was selected as a means of screening 
the efficacy of ovine campylobacteriosis vaccines.  In the study reported here, elimination 
of infection was considerably higher in animals receiving vaccine B (11/12 [92%]) or the 
experimental homologous bacterin (9/12 [75%]) versus those receiving vaccine A (2/13 
[15%]) or a sham-vaccination (3/14 [21%]).  This relative efficacy was maintained for 
each treatment independent of pregnancy status.  The efficacy of vaccine B was 
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statistically greater than that of the sham control treatment when analyzed overall or 
between subsets of pregnant and non-pregnant animals indicating a clear relationship 
between this product and resolution of infection with C. jejuni IA3902.  The homologous 
bacterin was slightly less efficacious than vaccine B and statistical significance versus 
controls was evident when comparing all animals treated; however, a statistically 
significant difference was not maintained when comparing pregnant subsets due to the 
low number of animals in each subset.  Administration of vaccine A failed to 
significantly reduce infection 48 hours after inoculation with IA3902 in any form of 
analysis.    
ELISA revealed that both commercial products and the experimental bacterin 
induced a significant level of Campylobacter-specific antibody relative to sham-
vaccinated controls.  This provides additional evidence of a difference in efficacy 
between the three treatments with regard to resolution of infection with C. jejuni IA3902, 
as the specificity of the antibodies in each group appears to differ despite a similar 
quantitative antibody response.  Vaccine B had a lower mean OD than either vaccine A 
or the experimental bacterin yet was associated with the highest level of efficacy based 
on resolution of infection.  While it is tempting to infer this as evidence of antibody 
quality over quantity, it is possible that a greater percentage of antibodies from vaccine B 
were consumed during the resolution of infection resulting in a lower OD in the 48 hour 
sera.  Further study with preinoculation serology is necessary to fully evaluate the 
quantitative difference in antibody level between treatments; however, observing the 
greatest resolution of infection in the group with the lowest mean OD suggests that each 
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treatment produced an adequate quantity of antibody and therefore makes vaccination 
failure an unlikely source of the observed differences between groups. 
C. jejuni was recovered from blood, bile, liver, and uterus in both pregnant and 
non-pregnant guinea pigs 48 hours post-inoculation, revealing that non-pregnant guinea 
pigs experience a similar overall tissue distribution relative to pregnant animals following 
IP inoculation with this organism.  In non-pregnant animals, the greatest relative quantity 
of C. jejuni was recovered from the bile, whereas in pregnant animals the placenta was 
the tissue associated with highest rates of recovery with considerably less recovery from 
the bile.  Previous studies have shown that C. jejuni is attracted to the mucin component 
of bile,
29
 and that certain bile acids induce virulence gene expression in C. jejuni,
30
 thus, 
identifying C. jejuni in the bile is not surprising.  However, the differential predilection 
for the bile in non-pregnant guinea pigs versus the placenta in pregnant animals observed 
in our current study is intriguing given that a recent report revealed C. jejuni is driven by 
energy taxis and seeks conditions most favorable for growth.
31
  The results of this present 
study may therefore suggest the presence of a placental factor more chemoattractive than 
bile that drives the placental tropism observed with this organism.  Further study 
involving the tropic effects of individual placental factors is necessary to further elucidate 
the nature of placental tropism with C. jejuni.   
In summary, the present study demonstrates that the evaluation of blood and 
tissue infection in both pregnant and non-pregnant guinea pigs 48 hours after IP 
inoculation can effectively be used to screen potential Campylobacter vaccines in a 
shorter, more cost-effective manner than that previously described.  Using this model, we 
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have shown that administration of two doses of vaccine B to both pregnant and non-
pregnant guinea pigs significantly reduced infection following IP inoculation with C. 
jejuni IA3902 comparable to that of a homologous bacterin while administration of 
vaccine A was ineffective despite inducing a significant level of Campylobacter-specific 
antibody.  This underscores the importance of efficacy testing against emergent 
pathogenic strains and provides further evidence of inadequate cross protection between 
heterologous C. jejuni strains.  These findings also suggest the presence of common 
protective antigens shared by the strains included in vaccine B and the challenge strain 
IA3902.  Further studies such as immunoblotting with representative sera from the 
different groups may provide clues to this observation.  As C. jejuni IA3902 has recently 
been described as the predominant ovine abortion-associated isolate in multiple states,
4
 
protection against this emergent strain should be an essential component of effective 
campylobacteriosis disease management programs, and the added fact that IA3902 is 
highly resistant to tetracycline increases the importance of vaccination in disease 
prevention.  Given the remarkably high percentage of guinea pigs receiving vaccine B 
(11/12 [92%]) that were free of infection 48 hours post-inoculation with a quantity of C. 
jejuni IA3902 previously shown to induce abortion in 100% of inoculated animals,
19
 it is 
likely that vaccine B would be the most effective currently available commercial vaccine 
for controlling ovine campylobacteriosis due to this specific strain; however, these 
findings do not necessarily reflect the effectiveness of either commercial product against 
the broad spectrum of Campylobacter spp. sheep may encounter in the field.  
Additionally, the high level of efficacy observed with the experimental homologous 
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bacterin in this study suggests that in vaccinated flocks experiencing abortion due to an 
unspecified strain of Campylobacter, an autogenous product may be an appropriate 
consideration.    
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Footnotes 
a. Campylobacter fetus bacterin (serial #1369B), Colorado Serum, Denver, CO 
b. Campylobacter fetus-jejuni bacterin (serial #06-251), Hygieia Laboratories, 
Woodland, CA 
c. Elm Hill Labs, Chelmsford, MA 
d. Aluminum hydroxide gel (13mg/ml), Sigma-Aldrich, St. Louis, MO 
e. Preston Campylobacter selective supplement, Oxoid Ltd, Cambridge, England 
f. Campylobacter growth supplement, Oxoid Ltd, Cambridge, England 
g. Nunc-Immune plate, Nunc, Denmark 
h. Anti-Guinea Pig IgG (H+L), peroxidase labeled, KPL, Gaithersburg, MD 
i. ABTS 2-Component Microwell Peroxidase Substrate, KPL, Gaithersburg, MD 
j. FLUOstar Omega Microplate Reader, BMG Labtech Inc, Durham, NC 
k. SAS 9.2, SAS Institute, Cary, NC 
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Table 1.  Summary of vaccination-related differences in blood and tissue 
cultures 48 hours after intraperitoneal inoculation with C. jejuni 
Vaccine type Blood Bile Liver   Uterus Placenta 
All animals      
   Sham 6/14 6/13† 10/14 5/14 3/3 
   Vaccine A 4/13 9/13 9/13 8/13 2/2 
   Vaccine B 0/12* 0/12* 1/12** 0/12* 1/7* 
   Bacterin 1/12 0/12* 3/12* 2/12 2/7 
Pregnant animals only      
   Sham 2/3 0/2† 2/3 3/3 3/3 
   Vaccine A 2/2 2/2 2/2 2/2 2/2 
   Vaccine B 0/7 0/7 1/7 0/7** 1/7* 
   Bacterin 1/7 0/7 2/7 2/7 2/7 
Non-pregnant animals only      
   Sham 4/11 6/11 8/11 2/11  
   Vaccine A 2/11 7/11 7/11 6/11  
   Vaccine B 0/5 0/5 0/5* 0/5  
   Bacterin 0/5 0/5 1/5 0/5  
Values reported represent the number of samples with positive culture results/number of samples tested.        
†A bile sample was unavailable from one guinea pig in this group.  *Values vary significantly from sham-
vaccinated controls (P < 0.05).  **Values vary significantly from sham-vaccinated controls (P < 0.01). 
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Table 2.  Semiquantitative recovery of C. jejuni from necropsy samples obtained 
from animals not protected by vaccination against intraperitoneal challenge with 
IA3902 
 Quantity of organisms recovered* 
Sample source Blood Bile Liver Uterus Placenta 
Pregnant animals      
Sham +++ - ++ +++ +++ 
Sham - - - + +++ 
Sham +++ † ++ +++ +++ 
Vaccine A +++ ++ ++ ++ +++ 
Vaccine A +++ +++ +++ +++ +++ 
Vaccine B - - + - +++ 
Bacterin + - + ++ +++ 
Bacterin - - +++ ++ +++ 
Non-pregnant animals      
Sham - - + -  
Sham + +++ + -  
Sham + +++ + -  
Sham + + + -  
Sham + +++ + -  
Sham - +++ + +  
Sham - +++ ++ -  
Sham - - + +  
Vaccine A - ++ + -  
Vaccine A + +++ + +  
Vaccine A - +++ ++ -  
Vaccine A + - - -  
Vaccine A - +++ + +  
Vaccine A - - - +  
Vaccine A - +++ + +  
Vaccine A - +++ + +  
Vaccine A - +++ + +  
Bacterin - - + -  
Total # positive 11/26 15/25 23/26 15/26 8/8 
* - = no growth; + = low growth (< 50 CFUs); ++ = moderate growth (50 – 1000 CFUs); +++ = high growth (> 1000 
CFUs); † = no sample available. 
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Figure 1.  Summary of serum antibody levels by treatment group (mean ± SEM).  
Antibody level represents the mean optical density (OD) as determined by ELISA on 
serum samples obtained from guinea pigs at necropsy 48 hours after IP inoculation with 
C. jejuni IA3902.  **Values vary significantly from sham-vaccinated controls (P < 0.01).  
*** Values vary significantly from sham-vaccinated controls (P < 0.001). 
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Figure 2.  Summary of vaccine efficacy by treatment group.  Percent free of infection 
represents the number of animals with negative Campylobacter culture results in all 
tissues sampled/total number of animals sampled.  Samples were obtained from guinea 
pigs at necropsy 48 hours after IP inoculation with C. jejuni IA3902.  *Values vary 
significantly from sham-vaccinated controls (P < 0.05).  ** Values vary significantly 
from sham-vaccinated controls (P < 0.01). 
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Abstract 
In the United States, a single clone of Campylobacter jejuni (named clone SA for 
Sheep Abortion) has recently been identified as a predominant cause of ovine abortion 
across multiple states, spanning multiple lambing seasons.  We have previously described 
the pregnant guinea pig as a model for studying this clone, and have demonstrated that 
this organism has a marked predilection for the subplacenta while sparing the placental 
disc in this species.  In the study described here, we compare the effects of subplacental 
and placental factors as well as bile and plasma from pregnant and non-pregnant guinea 
pigs on the growth and chemotaxis of C. jejuni IA3902, a field isolate of clone SA, 
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versus a reference strain (NCTC 11168).  Both strains grew better in subplacental tissue 
extracts at 24 hours; however, only IA3902 maintained this enhancement at 48 hours.  
Histochemistry and lectin histochemistry were used to localize mucin, iron, and L-fucose 
within the placental unit.  These individual factors along with progesterone and estradiol 
were evaluated for effects on growth and chemotaxis of C. jejuni.  Mucin, iron and L-
fucose were growth promoting while L-fucose was also chemotactic for both strains.  
Progesterone, estradiol and pregnant guinea pig plasma did not affect growth or 
chemotaxis, and no difference was observed when bile from pregnant and non-pregnant 
animals was compared.  These findings demonstrate specific factors within the guinea pig 
placental unit that drive chemotaxis and enhance growth of C. jejuni, shedding light on 
potential mechanisms underlying the fetoplacental tropism observed with this strain.   
 
Introduction 
Campylobacteriosis is a significant cause of ovine abortion worldwide with 
abortion rates ranging from 5-50% in affected flocks.
1
  In a 2001 survey by the United 
States Department of Agriculture, campylobacteriosis ranked first among infectious 
causes of abortion in domestic sheep.
2
  Recent studies have revealed that Campylobacter 
jejuni has become the predominant species associated with ovine abortions in the United 
States,
3,4
 and further analysis using pulsed-field gel electrophoresis has demonstrated that 
within these C. jejuni isolates a single tetracycline-resistant clone (named clone SA for 
Sheep Abortion) has emerged as the predominant cause of ovine abortion in Iowa, South 
Dakota, Idaho, California, Oregon, and Nevada.
4
  The identification of this single clone 
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recovered from abortions in different regions and during different lambing seasons is 
significant in that Campylobacter spp. traditionally exhibit marked genetic and antigenic 
heterogeneity.
3,5-7
   
The chemotactic behavior of C. jejuni has been described in response to specific 
chemical elements, with strong chemoattraction observed towards mucin, L-fucose, and 
bile.
8
  Additionally, it has been shown that not only is C. jejuni drawn toward specific 
environmental stimuli, but that these stimuli also support its growth and therefore this 
response is a form of energy taxis driving the organism toward optimal conditions for 
growth.
9
  To the authors’ knowledge, the effects of the sex hormones progesterone and 
estradiol on the growth and chemotaxis of C. jejuni has not been described; however, 
significant in vitro growth enhancement in the presence of both chemicals has been 
reported with Campylobacter rectus,
10
 and no effect was noted in the presence of 
progesterone with Campylobacter fetus subsp. venerealis.
11
    
We have previously demonstrated the high virulence of clone SA using pregnant 
guinea pigs as a model for studying abortion following oral inoculation with C. jejuni 
IA3902, a field isolate of clone SA, which induced abortion at a rate of 60%; whereas 
oral inoculation with C. jejuni NCTC 11168 or a sheep fecal isolate did not induce 
abortion in any inoculated animals.
12
  In this previous study,
12
 C. jejuni IA3902 was 
recovered from the blood, bile, feces, uterus and placenta of aborting animals, while 
NCTC 11168 and the sheep fecal isolate were only recovered from the feces.  This 
finding strongly indicates that IA3902 is highly invasive and causes systemic infection in 
pregnant animals.  Using immunohistochemistry, we have localized C. jejuni organisms 
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primarily within subplacental trophoblasts, the lateral aspects of the subplacental/decidual 
junctional zone, and surrounding maternal arteries in the decidua while the main placenta 
was spared,
12
 suggesting that C. jejuni IA3902 is differentially localized in the placental 
unit.  Despite these advances in understanding of the pathogenesis of clone SA, the 
factors influencing its pathogenicity and differential localization in infected tissues are 
still unknown.  The specific aims of this current study were fourfold:  1) to compare the 
growth and chemotaxis of IA3902 versus NCTC 11168 in tissue extracts from the guinea 
pig subplacenta and placenta, 2) to characterize the spatial distribution of putative growth 
promoting factors in various regions of the guinea pig placental unit, 3) to evaluate the 
effects of these potential factors on the growth and chemotaxis of IA3902 and NCTC 
11168 in vitro, and 4) to compare the effects of pregnant versus non-pregnant guinea pig 
plasma and bile on the growth and chemotaxis of both strains.  These studies were 
undertaken in an effort to shed light on potential mechanisms that may underlay the 
fetoplacental tropism and spatial localization of C. jejuni IA3902 during septic abortion 
in guinea pigs.  
  
Materials and Methods 
Humane animal care and use—All procedures described herein were approved 
by the Institutional Animal Care and Use Committee (IACUC) at Iowa State University, 
Ames, IA  50011. 
Animals—20 female Hartley guinea pigs were obtained from a commercial 
source (Elm Hill Labs, Chelmsford, MA).  Upon arrival, 10 of the animals were pregnant 
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at approximately 35 days of gestation and 10 were non-pregnant.  Pregnancy was 
confirmed by abdominal palpation.  Guinea pigs were group housed, provided wood chip 
bedding, fed a commercial pelleted guinea pig diet ad libitum, and allowed to acclimate 
for 5 days.   
Euthanasia and necropsy sampling—All animals were euthanized 5 days after 
arrival via IP injection of sodium pentobarbital (approximately 150 mg/kg) and 
necropsied immediately.  At necropsy, pregnant animals were placed in dorsal 
recumbency, the abdominal hair was clipped and the skin was aseptically prepared with 
povidone scrub and alcohol.  A sterile surgical drape was placed over the prepared 
abdominal skin and sterile surgical instruments were used to incise the abdomen and 
exteriorize the gravid uterus.  The entire uterus was removed intact and carefully 
transferred to a laminar flow hood before further processing.  Once under the hood, the 
uterus was incised with a sterile surgical blade and each placental disc along with its 
associated subplacenta was carefully removed as a unit.  Each placental unit was then cut 
in half longitudinally and one part was placed in 10% neutral buffered formalin while the 
other half was prepared for use in the in vitro growth and taxis assays.  In preparation for 
these assays, careful aseptic technique was used to separate the subplacenta from the 
placental disc using sterile curved surgical scissors.  The separated subplacenta and 
placental disc were placed into separate sterile specimen bags (Whirl-pak, Nasco, USA) 
and then pooled for pairs of guinea pigs to yield a total of 5 samples for analysis.  For 
both pregnant and non-pregnant animals, heart blood and bile were collected using sterile 
needles and syringes, blood samples were placed in anticoagulant tubes, and plasma was 
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separated for analysis.  Due to small sample volumes, plasma samples were also pooled 
for each pair of guinea pigs (5 samples total) and bile samples were pooled for groups of 
two or three guinea pigs (4 samples total).  Placental samples taken for histopathology 
remained in neutral buffered formalin for 24 hours and were then embedded in paraffin 
and processed routinely for histochemical staining.   
Histology and histochemistry—Serial sections from each placenta were cut to 5 
µm and stained with Perl’s iron stain, Alcian blue pH 2.5, and the periodic acid-Schiff 
reaction with and without diastase pretreatment.  Sections were evaluated to determine 
the presence or absence of material with staining characteristics consistent with iron, acid 
mucin, and neutral mucin within the different aspects of the placental unit (placental disc, 
visceral yolk sac placenta, parietal yolk sac placenta, subplacenta, and decidual junctional 
zone).  Each area of each placenta was then quantified subjectively based on the amount 
of positive staining noted in a random 40X field [negative (-) if no staining was observed, 
low (+) if < 10% of the field stained positively, moderate (++) if 10 – 25% staining was 
observed, and abundant (+++) if > 25% of the field stained positive].  Staining was also 
evaluated for distribution within each tissue type and classified as intracellular or 
extracellular and multifocal or diffuse.  
Lectin histochemistry—Serial sections from each placenta were cut to 3 µm, 
placed on aminoalkylsilane coated glass slides and placed in a 56ºC oven for 2 hours.  
Sections were routinely deparaffinized in xylene and rehydrated in graded alcohol and 
water baths.  To inhibit endogenous peroxidase, sections were immersed (2 immersions; 
10 min/immersion) in 3% hydrogen peroxide in water.  For antigen unmasking, sections 
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were treated with Tris-EDTA (pH 9.0) in a stream bath for 20 minutes, allowed to cool to 
room temperature, and then rinsed three times in PBS prior to placement in an automated 
cell staining system (BioGenex, USA).  Lectins employed consisted of commercially 
available biotinylated Ulex europaeus agglutinin I (UEA-I [Vector, USA]) and 
biotinylated Lotus tetragonolobus lectin (LTA [Vector, USA]) applied to sections at 20 
µg/ml and incubated at 22
o
C for 30 minutes followed by rinsing in a bath of PBS solution 
for 5 minutes.  Lectin binding was visualized using a commercial kit (Vectastain Elite 
ABC, Vector, USA) and chromogen (NovaRED, Vector, USA) per manufacturer 
instructions and the sections were then counterstained with hematoxylin and mounted 
routinely.  Specificity of lectin binding was confirmed by preabsorbing lectins in 250 mM 
of L-fucose prior to application to serial sections.  Complete elimination of binding was 
observed after preabsorption with UEA-I and complete to markedly reduced binding was 
observed with LTA.  Negative controls were prepared from serial sections in which the 
lectin was omitted and the dilution buffer was applied in its place.  Sections were 
evaluated to determine the presence or absence of binding within the different aspects of 
the placental unit (placental disc, visceral yolk sac placenta, parietal yolk sac placenta, 
subplacenta, and decidual junctional zone).  Lectin binding in each area of each placenta 
was then quantified subjectively based on the distribution and intensity of positive 
staining in a random 40X field [negative (-) if no staining was observed, low (+) if mild 
scattered cytoplasmic staining was observed, moderate (++) if mild to moderate 
cytoplasmic and multifocal apical membrane staining was observed, and abundant (+++) 
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if moderate to marked cytoplasmic and strong diffuse apical membrane staining was 
observed].   
Growth assays—Subplacental and placental tissues were placed in PBS (10% 
w/v), crushed mechanically via hand, centrifuged at 1000g for 5 minutes to remove large 
tissue fragments, and the resultant supernatants were collected for use in the growth 
assays.  Plasma samples were heat-treated at 56°C for 30 minutes prior to use to 
inactivate complement and bile samples were used directly.  For all biological samples, 
100 µl from an overnight culture of C. jejuni (grown on MH agar under microaerophilic 
conditions at 42°C) that had been adjusted to an OD600 of 0.1 (approximately 1 X 10
7
 
CFU/ml) in PBS, was inoculated into separate culture tubes containing 2 ml of the 
biological sample to be tested.  At 24 and 48 hours, 100 µl of each inoculated sample was 
then plated onto MH agar plates at different dilutions to determine the number of colony-
forming units (CFUs) for each sample. 
Commercially available mucin (hog gastric), L-fucose, progesterone, estradiol 
(Sigma, USA) and iron were obtained for use as substrates in the growth assays. 
Progesterone and estradiol were dissolved in DMSO:PBS (1:4), while other chemicals 
were dissolved in PBS.  Mucin was autoclaved at 121°C for 15 minutes prior to use and 
all other chemicals were filter sterilized using a 0.45 µm filter.  Each substrate was added 
to minimum essential medium (MEM α [cat. #41061-029], Invitrogen, USA) to obtain 
the following solutions separately:  mucin (0.1%); iron (40 µM); L-fucose (0.05 M) + 
iron (40 µM); progesterone (50 ng/ml) + iron (40 µM); and estradiol (50 ng/ml) + iron 
(40 µM).   For all prepared solutions, 10 ml of each was inoculated with 100 µl of OD600 
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of 0.1 C. jejuni cells in MEM Alpha (resulting in an initial OD600 of approximately 0.001) 
and incubated under microaerophilic conditions at 42°C.  At 24, 48, and 72 hours, tubes 
containing each inoculum were shaken at 130 rpm and the OD600 value was determined 
using a spectrometer. 
Chemotaxis assays— A fresh overnight culture of each Campylobacter jejuni 
strain (IA3902 and NCTC 11168) on Mueller-Hinton (MH) agar plates was harvested in 
MH broth, pelleted by centrifugation at 5000g for 5 minutes, and then resuspended in 
PBS with the bacterial concentration adjusted spectrophotometrically to approximately 4 
x 10
9
 CFU/ml with temperate PBS soft agar (0.4%) as described by others.
8,9
  12 ml of 
bacterial suspension was poured into a 90 mm sterile Petri dish and 6 mm sterile filter 
discs (Whatman) saturated with approximately 50 µl of test solution were placed on the 
solidified bacterial suspension.  Solutions tested included subplacental and placental 
extracts (10% and 50% solutions as prepared in the growth assays), undiluted plasma, 
undiluted heat inactivated plasma, undiluted non-pregnant bile, pregnant bile (25%, 50%, 
and 100%), iron (0.01 M in double distilled water), mucin (0.1% and 1.0% solutions 
autoclaved at 70°C for 30 minutes), L-fucose (0.1 M in double distilled water), 
progesterone (50 ng/ml in 1:4 DMSO:PBS), and estradiol (50 ng/ml in 1:4 DMSO:PBS).  
After 4 hours of incubation at 42°C under microaerophilic conditions, chemotactic 
activity was examined over a light source.  Bacterial accumulation around filter discs or 
zones of clearing were interpreted as zones of attraction or repulsion, respectively.  
Deoxycholic acid (0.1 M) was used as a control for chemical repulsion based on results 
125 
 
from a previous study.
9
  For mucin, chemotaxis was also measured using the hard-agar 
plug assay as described by others.
8
 
Statistical analysis—A commercial statistical software package (JMP 8.0.2, SAS 
Institute Inc., USA) was used to perform all analyses.  Independent samples t-tests were 
utilized to detect differences in growth rates by strain in the tissue homogenate assays, 
and by pregnancy status in the bile assays.  One-way ANOVA was used to detect 
differences in growth rates between multiple substrates with P values reported after 
Tukey adjustment for multiple comparisons.  Fisher’s exact test for binomial variables 
was employed when comparing the presence or absence of positive Campylobacter 
culture by pregnancy status in the plasma assays. 
 
Results 
Histology and histochemistry—In sections stained with the periodic acid-Schiff 
reaction following diastase pretreatment, abundant PAS positive material, compatible 
with neutral mucin, was present within subplacental lacunae (Figure 1a) while the 
associated lamellae did not stain.  Moderate to abundant PAS positive, diastase resistant 
extracellular material was also identified throughout the junctional zone with frequent 
marked perivascular accumulation.  A low level of diffuse apical cytoplasmic staining 
was noted in the visceral yolk sac endoderm while the parietal yolk sac and placental disc 
did not stain.  These results are summarized in Table 1.  
Staining with Alcian blue pH 2.5 revealed moderate amounts of globular 
extracellular material within subplacental lacunae (Figure 1b) consistent with acid mucin.  
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Similar material was present in moderate amounts within the junctional zone, most often 
along the lateral aspect and frequently surrounding the maternal arteries.  There was a 
low level of positive staining in the apical cytoplasm of cells lining vascular channels in 
the placental labyrinth and along the apical membrane of the parietal yolk sac endoderm.  
Cells of the visceral yolk sac endoderm were characterized by diffuse, strongly positive 
apical cytoplasmic and membrane staining.  These results are summarized in Table 1. 
Perl’s staining revealed low to moderate amounts of scattered intracellular and 
extracellular iron in the placental disc along the junction of the interlobium and the 
labyrinth (Figure 2) and surrounding large maternal blood lacunae.  Lesser amounts of 
scattered intracellular and extracellular iron were noted along the basal and less often 
lateral margins of the junctional zone.  No iron was noted in the subplacenta or either 
layers of the yolk sac in the sections evaluated.  These results are summarized in Table 1.  
Lectin histochemistry—For the two lectins tested (UEA-I and LTA), significant 
binding was only observed in the visceral yolk sac endoderm.  In sections treated with 
UEA-I, marked diffuse apical membrane binding was present in the endodermal cells in 
all sections (Figure 3a) with lesser amounts of granular cytoplasmic staining noted 
occasionally.  The underlying mesenchymal cells did not stain.  Treatment with LTA 
revealed moderate amounts of similar apical membrane binding in multifocal, 
individualized endodermal cells and moderate amounts of granular cytoplasmic staining 
(Figure 3b).  For both lectins, the membrane binding was completely inhibited following 
preincubation of the lectin with L-fucose solution.  Neither lectin reacted with vascular 
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endothelium in any of the sections evaluated, consistent with previous studies in guinea 
pigs and other rodents.
13
  The lectin binding results are summarized in Table 1. 
Growth assays—None of the biological or chemical preparations yielded 
microbial growth when plated on MH agar incubated at 37°C aerobically, indicating that 
the aseptic techniques employed during sample preparation had prevented microbial 
contamination that would otherwise have confounded interpretation of the results.  In the 
majority of the pooled placental tissues tested, higher CFU counts were noted for both 
strains of C. jejuni (IA3902 and NCTC 11168) in the subplacental tissues versus 
placental disc material at 24 hours.  Interestingly, at 48 hours, this enhanced growth in 
subplacental tissues was maintained only for IA3902, whereas NCTC 11168 began to 
grow better in the placental disc material and at this time point the growth multiples for 
each strain differed significantly (P = 0.0397).  The mean growth multiples for both 
strains at both time points are shown in Figure 4.   
At 24 hours, the incidence of bacterial survival was higher in non-pregnant 
plasma versus pregnant plasma for both strains; however, statistical significance was not 
attained in the analysis by strain due to low sample numbers associated with sample 
pooling.  CFU counts were generally low overall, suggesting an antimicrobial effect of 
the plasma.  Analyzing the incidence of bacterial survival at 24 hours without subdividing 
by strain revealed a significantly increased incidence in non-pregnant versus pregnant 
plasma (P = 0.0076), and these results are summarized in Figure 5.  At 48 hours, the 
incidence of bacterial survival did not differ by pregnancy status for either strain as 
organisms were not recovered from the majority of samples at this time point.   
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Due to the small volume of the bile samples, only IA3902 was tested in all 
samples and CFU counts did not differ significantly by pregnancy status at either 24 or 
48 hours (P = 0.5350 and P = 0.3844, respectively).  Mean CFU counts per ml for 
pregnant versus non-pregnant bile at 24 hours were 7.8 x 10
3
 and 5.5 x 10
3
, respectively.  
Three samples of bile were available for testing NCTC 11168, two pregnant and one non-
pregnant, and similar CFU counts were observed as with IA3902; however, statistical 
analysis was not performed given the low number of samples. 
Growth of C. jejuni in the presence of mucin, iron and L-fucose was compared to 
that in MEM control.  At 24 hours, growth of IA3902 in the presence of mucin was 
significantly greater than that in MEM control, L-fucose, and iron (P < 0.0001, P = 
0.0026 and P = 0.0074, respectively); whereas growth of NCTC 11168 in mucin was 
only significantly greater than that of the control (P = 0.0051).  Growth of IA3902 in the 
presence of iron at 24 hours was also significantly greater than that in controls (P = 
0.0270), while growth of NCTC 11168 was not significantly different (P = 0.4350).  At 
48 hours, growth in the presence of L-fucose was significantly greater than that in all 
other substrates for both IA3902 and NCTC 11168 (P < 0.0001, all comparisons).  
Additionally, growth in the presence of both iron and mucin was significantly greater 
than that in controls for both C. jejuni strains at this time point (P < 0.0001, all 
comparisons).  At 72 hours, growth in the presence of all three substrates was again 
significantly greater than that in MEM control for both C. jejuni strains (P < 0.0001, all 
comparisons), and growth of NCTC 11168 in the presence of L-fucose was greater than 
that in iron or mucin (P < 0.0001, P = 0.0003, respectively).  The mean growth rate in the 
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presence of each substrate and at each time point is summarized for both IA3902 and 
NCTC 11168 in Figure 6a and Figure 6b, respectively. 
The growth of C. jejuni in the presence of estradiol + iron, progesterone + iron, 
and iron alone was compared to that in MEM + DMSO control.  At 24 hours, growth in 
the presence of all three substrates was significantly greater than that in MEM + DMSO 
control for both IA3902 (P < 0.001, all comparisons) and NCTC 11168 (P < 0.02, all 
comparisons); however, there was no difference between growth in iron alone and iron 
with the addition of either hormone for either of the C. jejuni strains (P > 0.85, all 
comparisons).  At 48 and 72 hours, the results for both C. jejuni strains were similar to 
the 24 hour time point with growth in all three test substrates significantly higher than 
that in MEM + DMSO control (P < 0.001, all comparisons), and no significant difference 
observed between any of the iron or hormone combinations for either IA3902 (P > 0.13, 
all comparisons) or NCTC 11168 (P > 0.80, all comparisons).  The mean growth rates in 
the presence of each substrate and at each time point are summarized for both IA3902 
and NCTC 11168 in Figure 7a and Figure 7b, respectively. 
Chemotaxis assays— The results of the filter disc chemotaxis assays are 
summarized in Table 2.  No significant differences were noted between strains in 
response to any of the tested biological or commercial chemical samples.  The only tested 
chemical with positive chemoattraction was L-fucose (Fig 8a); while bile, regardless of 
pregnancy status, was strongly chemorepellent (Fig 8b).  For both strains, the diameters 
of the chemorepulsion zones were concentration dependent where larger diameters 
correlated to more concentrated bile.  For the 25%, 50% and 100% bile solutions from 
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pregnant animals, the respective zones of repulsion measured 11mm, 14mm and 17mm 
for strain IA3902, and 11mm, 13mm, and 15.5mm for strain NCTC 11168.  No effect 
was observed with mucin in the chemical-in-plug assay for either strain.  
 
Discussion 
The pathogenesis of ovine campylobacteriosis is complex and includes intestinal 
invasion, evasion of the host immune response, hematogenous dissemination, and 
fetoplacental colonization, which ultimately culminates in abortion of the fetus with 
recovery of Campylobacter in large numbers from expelled placentas.
14
  Affected flocks 
often experience waves of abortions involving 23.2% of the flock on average.
1
  The 
epidemiology of this disease is further complicated by the high prevalence rate of C. 
jejuni in domestic flocks,
15
 high numbers of healthy sheep with carriage in the bile,
16
 and 
the marked heterogeneity of strains encountered.
7,15
  Recently, a single clone of C. jejuni 
has been recognized as the predominant cause of Campylobacter-associated abortions in 
the United States,
4
 and we have previously demonstrated that the pregnant guinea pig is 
an effective model for studying this highly abortifacient clone.
12
  To the authors’ 
knowledge, factors that may drive the fetoplacental tropism of C. jejuni have not been 
previously described in any species.    
The guinea pig placenta consists of a discoid, labyrinthine main placenta with a 
separate yolk sac placenta and subplacenta.
17
  The subplacenta, a feature unique to 
histrichognath rodents, is composed of extensive lamellae of cytotrophoblasts lined by a 
layer of syncytiotrophoblast with large extensively vacuolated lacunae.
18
  The 
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subplacenta forms the frontal barrier at the maternofetal interface and penetrates the 
decidua forming the junctional zone.
18
  The subplacenta is separated from the main 
placenta by a layer of fetal mesenchyme,
19
 the lateral aspects of which are penetrated by 
the maternal arteries as they enter the placental disc.
18
  We have previously shown by 
immunohistochemistry that C. jejuni localizes within this junctional zone and within 
subplacental trophoblasts following oral infection,
12
 a seemingly appropriate location as 
this is the site of maternal vascular invasion.  In mid to late gestation, the placenta 
becomes a major source of progesterone production in guinea pigs, with hormone 
synthesis occurring in the spongy zone syncytiotrophoblast of the placental disc.
20
  The 
yolk sac placenta is inverted in the guinea pig, with its visceral endoderm facing the 
uterine lumen and in direct contact with the endometrium.
19,21
  The functions of this 
inverted yolk sac include receptor-mediated endocytosis, passage of maternal antibodies, 
and absorption, degradation and transfer of maternal serum proteins.
21,22
   
In the study reported here, we compared the effects of whole tissue extracts from 
two separate regions of the guinea pig placenta, as well as various subcomponents within 
each region, on the growth and chemotaxis of two strains of C. jejuni, IA3902 and NCTC 
11168.  These two strains were previously demonstrated to have markedly different 
abortive capacity following oral inoculation.
12
  Both strains responded similarly to all in 
vitro tests with the exception of the 48 hour growth assay in whole tissue extracts.  While 
both strains grew to higher numbers in the subplacental extracts at 24 hours, only IA3902 
maintained this preferential growth at 48 hours suggesting a potential difference between 
the two strains in their ability to grow within various regions of the guinea pig placenta.  
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This is significant in that our previous immunohistochemical studies have shown that 
IA3902 colonizes the subplacenta and junctional zone while the main placenta is spared.   
Previously published studies on the growth and chemotaxis of Campylobacter 
spp. provided potential target compounds to evaluate within the placenta, including 
mucin, L-fucose, iron, estrogen and progesterone.
8,10,23,24
  In an attempt to further explain 
the fetoplacental tropism we have observed with IA3902, we performed histochemical 
techniques to localize these potential growth promoting substances within the guinea pig 
placenta.  Experimental studies have revealed that both hog gastric and bovine gall 
bladder mucin support the growth of C. jejuni.
8
  Accordingly, we have identified 
moderate to abundant amounts of both acid and neutral mucin within subplacental 
lacunae and the junctional zone, consistent with our previous immunohistochemical 
localization of C. jejuni in tissues from aborting guinea pigs,
12
 while the main placenta 
contained only scant amounts of acid mucin.  Previous studies have demonstrated that C. 
jejuni has the capacity to utilize iron from host sources,
23
 and acquisition of iron appears 
important in the pathogenesis of Campylobacter infection as reduced growth of C. jejuni 
has been demonstrated in low-iron environments.
24
  In the study reported here, low to 
moderate amounts of scattered intracellular and extracellular iron were observed in both 
the junctional zone and the placental disc.   
The results of the 24 hour growth assays revealed that mucin significantly 
enhanced growth of both strains of C. jejuni versus controls and that for IA3902 this 
growth was also significantly greater than that in the presence of iron or L-fucose.  
Additionally, growth in the presence of iron at 24 hours was significantly greater than 
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that of controls for IA3902.  Enhanced growth in the presence of iron and mucin versus 
MEM control was evident for both strains at the 48 and 72 hour time points.  The 
demonstration of strongly growth promoting substances in the same location where we 
have previously identified C. jejuni by immunohistochemistry suggests energy taxis as an 
underlying mechanism for this localization rather than simple dissemination subsequent 
to bacteremia, and this is consistent with previous studies whereby C. jejuni has been 
shown to undergo energy taxis toward conditions most favorable for growth.
9
  L-fucose 
was also strongly growth promoting, particularly at the 48 hour time point for both strains 
tested.  This finding is intriguing as C. jejuni has been shown to utilize L-fucose as a 
growth substrate in a strain-specific manner, and both IA3902 and NCTC 11168 harbor 
the operon responsible for this utilization.
25
  Our lectin binding assays revealed L-fucose 
compatible residues only in the visceral yolk sac placenta, a site where we have not yet 
identified C. jejuni immunohistochemically; however, the yolk sac placenta was not 
specifically evaluated in our previous work and initial organism localization in this region 
of the placenta cannot be definitively ruled out. 
Bacterial survival in plasma and bile from both pregnant and non-pregnant guinea 
pigs was compared to determine if a pregnancy related factor present in these fluids, such 
as the hormones progesterone and estradiol, might enhance the growth of either strain of 
C. jejuni.  For both strains, the incidence of bacterial survival was higher in non-pregnant 
versus pregnant plasma at 24 hours, and neither strain showed enhanced growth in the 
presence of either progesterone or estradiol in the individual factor assays suggesting that 
these hormones do not stimulate the growth of either strain.  This is in contrast to a 
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previous report of enhanced growth in the presence of both hormones with C. rectus,
10
 
and in agreement with previous findings of no growth enhancement in the presence of 
progesterone with C. fetus subsp. venerealis.
11
  Both strains survived well in the presence 
of bile regardless of pregnancy status, again suggesting that soluble factors of pregnancy 
in the guinea pig and their metabolites do not directly enhance the growth of either C. 
jejuni IA3902 or NCTC 11168.  These findings are of particular note with regard to 
progesterone, as pregnant guinea pigs have markedly elevated midgestational plasma 
progesterone levels, with a roughly fifty-six fold increase versus non-pregnant controls.
26
   
C. jejuni responds to its environment, undergoing chemotaxis toward a variety of 
specific chemical substrates
8
 and ultimately toward areas that will enhance its growth.
9
  
We were particularly interested in the potential chemotactic effects of progesterone as 
both guinea pigs and sheep have increasing placental synthesis of progesterone as 
pregnancy advances
20,27
 which might serve to explain the late gestational incidence of 
ovine campylobacteriosis and the marked tropism of this organism for the placenta; 
however, we did not observe chemotaxis of either strain toward progesterone, pregnant 
plasma, or extracts from the placental disc, suggesting that neither strain responds 
directly to the presence of progesterone.  We did observe marked chemotaxis of both 
strains toward L-fucose, consistent with a previous study involving two different strains 
of C. jejuni.
8
  This finding is significant in that our lectin binding assays detected the 
presence of both UEA-I and LTA reactive residues along the apical membrane of the 
visceral yolk sac placenta, consistent with -L-fucose containing surface glycans.28  The 
apical surface of the visceral yolk sac epithelium is in direct contact with the 
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endometrium as gestation progresses
17
 and, as the yolk sac is thought to serve in 
maternofetal exchange,
21
 it may serve as another potential entry point for C. jejuni into 
the guinea pig placenta during episodes of bacteremia.  At the very least, the presence of 
abundant L-fucose residues within the fetoplacental unit suggests that chemotaxis 
towards this particular chemical may play a role in the fetoplacental tropism in this 
species.   
Previous chemotaxis studies involving C. jejuni have revealed chemoattraction 
towards several types of mucin
8,9,29
 which we could not confirm in the present study 
using swine gastric mucin in either the saturated filter disc or hard-agar plug procedure.  
While chemotaxis of C. jejuni toward hog gastric mucin has been demonstrated 
previously using a hard-agar plug procedure,
8
 the strains tested in that particular study did 
not include either IA3902 or NCTC 11168, raising the possibility that strain-related 
differences in chemotaxis may occur.  Additionally, two recent studies have raised 
concern about the potential for false positive results in chemical-in-plug chemotaxis 
assays, as apparent chemotaxis has been observed in motility deficient mutant strains of 
C. jejuni
30
 and other bacteria.
31
  
Gall bladder colonization and fecal shedding may be important in the 
maintenance of Campylobacter spp. in an animal population.  In previous studies in our 
laboratory, IA3902 has been isolated from the bile of both pregnant and non-pregnant 
guinea pigs, and C. jejuni has been recovered from the bile of healthy sheep at 
slaughter.
16,32,33
  Interestingly, in the present study, bile, regardless of pregnancy status, 
was strongly chemorepellent for both IA3902 and NCTC 11168, and the diameter of the 
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zones of chemorepulsion was concentration dependent where larger diameters correlated 
with more concentrated bile.  This is in contrast to a previously published study where 
diluted bovine and chicken bile were described as chemoattractive for C. jejuni strains of 
chicken fecal origin;
8
 however, in the same study, the residual bile components after 
removal of the mucin fraction were strongly chemorepellent for all tested strains.  Taken 
together these findings would suggest that the observed chemorepulsive effect of bile in 
the present study is due either to differences in the composition (e.g. mucin) of guinea pig 
bile relative to that of bovine or chicken origin, or potentially due to strain-specific 
responses of C. jejuni.   
In summary, we have demonstrated the presence of specific elements within the 
guinea pig placenta that enhance growth (iron, mucin, L-fucose) and drive chemotaxis 
(L-fucose) of C. jejuni.  Furthermore, we have identified two of these elements (iron, 
mucin) within the subplacenta and the decidual interface, consistent with our previous 
immunohistochemical localization of C. jejuni in these same areas in aborted tissues 
following inoculation with C. jejuni IA3902.  These findings suggest a potential 
underlying mechanism for the marked placental tropism we have observed with this 
strain; however, as we observed similar in vitro effects with both a known abortifacient 
strain (IA3902) and a reference strain (NCTC 11168) that did not induce abortion 
following oral inoculation,
12
 differences in response to particular placental or pregnancy-
associated factors alone do not appear to be responsible for the differing abortifacient 
potential of these two strains.  Further work is required to better elucidate mechanisms 
underlying the marked difference in abortive capacity observed between Campylobacter 
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strains following oral inoculation including intestinal invasive capacity, virulence gene 
expression, level of bacteremia, and evasion of the host immune response.  While we 
have utilized a guinea pig model to identify potential host factors that may underlie the 
extensive fetoplacental tropism observed in vivo, additional studies are required to 
determine if similar factors are present in the late gestational ovine placenta as this is the 
target species and the time during which the preponderance of Campylobacter-associated 
abortion occurs.   
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Table 1 – Summary of histochemistry and lectin histochemistry findings 
 Subjective quantification of staining* 
 
Tissue type 
Neutral 
mucin 
Acid      
mucin 
Iron‡ UEA-1† LTA† 
   Placental disc - + + - - 
   Visceral yolk sac placenta ++ +++ - +++ ++ 
   Parietal yolk sac placenta + ++ - - - 
   Subplacental lacunae +++ ++ - - - 
     Junctional zone +++ ++ + - - 
Values reported represent the average of all evaluated placental materials from 10 guinea pigs tested.                   
* - = negative; + = low; ++ = moderate; +++ = abundant.                                                                                         
‡ = multifocal staining; † = apical membrane staining. 
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Table 2 – Summary of chemotactic responses of C. jejuni by strain 
 Taxis response* 
Test sample IA3902 NCTC 11168 
  Subplacenta (10%, 50%) 0,0 0,0 
  Placental disc (10%, 50%) 0,0 0,0 
  Mucin, porcine stomach (0.1%, 1%) 0,0 0,0 
  L-Fucose (0.1M)  + + 
  Iron [Fe2(SO4)3] (0.01M) 0 0 
  Plasma (pregnant, heat inactivated) 0 0 
  Plasma (pregnant, untreated) 0 0 
  Progesterone (50ng/ml) 0 0 
  Estradiol (50ng/ml) 0 0 
  Bile, pregnant (25%, 50%, 100%) -,-,- -,-,- 
  Bile, non-pregnant (100%) - - 
  Deoxycholic acid (0.1M) - - 
* + = attraction; 0 = no response; - = repulsion 
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Figure 1.  Subplacenta; guinea pig; histochemistry for mucoprotein.  (a) Subplacental 
lacunae (*) and junctional zone (^) containing abundant PAS+ material.  Periodic acid-
Schiff reaction.  (b) Subplacental lacunae (*) containing moderate amounts of acid mucin 
and moderate to abundant amounts within the junctional zone (^) and surrounding 
maternal blood vessels (arrow).  Alcian blue, pH 2.5. 
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Figure 2.  Placenta; guinea pig; histochemistry for iron.  Moderate amounts of iron 
(blue staining) are present within the placental disc along the junction of the interlobium 
and the labyrinth.  The parietal yolk sac placenta is at left.  Perl’s iron stain.  
Figure 3.  Visceral yolk sac placenta; guinea pig; lectin histochemistry for L-fucose.  
(a) Peroxidase staining of Ulex europaeus agglutinin I (UEA-I) binding sites.  
Endodermal cells have abundant diffuse apical membrane labeling with scant 
cytoplasmic reactivity while the underlying mesenchyme is non-reactive.  Harris’ 
hematoxylin counterstain.  (b) Peroxidase staining of Lotus tetragonolobus lectin (LTA) 
binding sites.  Multifocal and often individualized endodermal cells (arrowheads) have 
abundant diffuse apical membrane labeling while the majority of endodermal cells have 
scant to moderate cytoplasmic reactivity and the underlying mesenchyme is non-reactive.  
Harris’ hematoxylin counterstain.   
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Figure 4.  Summary of mean growth multiples in placental tissues at 24 and 48 
hours.  Values represent the mean growth multiple (CFUs in subplacental extracts / 
CFUs in placental disc extracts) for C. jejuni strains IA3902 and NCTC 11168.  At 48 
hours, values differed significantly (* = P = 0.0397) indicating greater growth of strain 
IA3902 versus NCTC 11168 in subplacental extracts at this time point. 
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Figure 5.  Summary of the incidence of bacterial survival at 24 hours in pregnant 
versus non-pregnant plasma.  Shaded areas of the graphs represent the proportion of 
samples from which bacteria were recovered (incidence of bacterial survival) for both C. 
jejuni IA3902 and NCTC 11168 combined.  The incidence of survival in non-pregnant 
plasma was significantly greater (P = 0.0076). 
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Figure 6.  Summary of mean growth rates (OD600) of C. jejuni in the presence of 
individual placental factors at 24, 48 and 72 hours.  (a) Growth of IA3902 was 
significantly higher in the presence of mucin than all other factors at 24 hours, while 
growth in iron was also greater than MEM control.  At 48 hours, growth of IA3902 was 
significantly higher in the presence of L-fucose than all other factors and growth in iron 
and mucin was also greater than that in MEM control.  At 72 hours, growth of IA3902 
was significantly higher in all three test substrates relative to MEM control.  (b) Growth 
of NCTC 11168 was significantly higher in the presence of mucin than that in MEM 
control at 24 hours.  At 48 hours, growth of NCTC 11168 was significantly higher in the 
presence of L-fucose than all other factors and growth in iron and mucin was also greater 
than that in MEM control.  At 72 hours, growth of NCTC 11168 was significantly higher 
in all three test substrates relative to MEM control, and growth in the presence of L-
fucose was also greater than that in mucin or iron. 
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Figure 7.  Summary of mean growth rates (OD600) of C. jejuni in the presence of 
individual plasma factors at 24, 48 and 72 hours.  (a) At all time points, growth of 
IA3902 in the presence of all three iron containing treatments was significantly greater 
than that in MEM + DMSO control; however, no differences were observed with the 
addition of either progesterone or estradiol.  (b) At all time points, growth of NCTC 
11168 in the presence of all three iron containing treatments was significantly greater 
than that in MEM + DMSO control; however, no differences were observed with the 
addition of either progesterone or estradiol. 
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Figure 8.  Chemotaxis assays with C. jejuni suspended in PBS soft agar.  Filter discs 
saturated with test chemicals were placed onto solidified bacterial suspension and 
migrations zones measured after 4 hours of incubation at 42°C.  (a) Strain NCTC 11168 
showing chemoattraction toward a filter disc saturated with 0.1M L-fucose solution.  (b) 
Strain IA3902 showing strong chemorepulsion away from a filter disc saturated with 
undiluted pregnant guinea pig bile.  
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CHAPTER 6:  GENERAL CONCLUSIONS 
 
General Discussion 
 Ovine campylobacteriosis is frequently listed as one of the top three causes of 
sheep abortion worldwide,
1-4
 and has recently been identified as the leading cause of 
infectious abortion in the United States.
5
  Additionally, within campylobacters recovered 
from field cases of sheep abortion, a single clone of Campylobacter jejuni, named clone 
SA, has emerged accounting for 93% of the isolates from multiple states and spanning 
multiple lambing seasons.
6
  The central hypothesis for the studies described in this 
dissertation was that clone SA of C. jejuni is highly pathogenic with resistance to 
traditional prevention strategies and marked tropism for the fetoplacental unit.  The work 
in this dissertation supports our central hypothesis in four ways as data generated from 
these studies:  1) confirm the highly pathogenic nature of C. jejuni clone SA in a pregnant 
guinea pig model, 2) describe alterations in expression of TLRs in trophoblasts from 
guinea pigs infected with IA3902, a field isolate of clone SA, 3) reveal variability in the 
efficacy of commercially available Campylobacter vaccines in preventing infection of 
guinea pigs with IA3902, and 4) characterize the spatial distribution of specific factors 
within the guinea pig placenta that promote growth and drive chemotaxis of C. jejuni 
IA3902.       
Oral inoculation of pregnant guinea pigs is an effective model to study the 
pathogenesis of abortion due to C. jejuni IA3902 
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Although intraperitoneal inoculation of pregnant guinea pigs has been described 
as a model for assessing virulence of Campylobacter spp.,
7-9
 this type of inoculation does 
not fully replicate disease caused by abortifacient campylobacters where oral exposure is 
the natural route.
10
  A previous report describing oral inoculation of human-origin 
Campylobacter spp. into pregnant guinea pigs failed to induce abortion;
9
 however, we 
hypothesized that highly abortifacient campylobacters of ovine-origin, such as C. jejuni 
clone SA, would be effective in inducing abortion after oral inoculation in guinea pigs.  
In Chapter 2, we demonstrated that oral inoculation of C. jejuni IA3902, a field isolate of 
clone SA, into pregnant guinea pigs was indeed effective in reproducing disease similar 
to that observed in sheep with the induction of abortion in 60% (6/10) of inoculated 
animals and a 70% (7/10) fetoplacental infection rate.  Additionally, we demonstrated 
that oral inoculation of pregnant guinea pigs with a reference strain (C. jejuni NCTC 
11168) and a commensal strain from sheep feces resulted in a high level of intestinal 
colonization at 21 days postinoculation but did not induce abortion or result in 
fetoplacental infection in any of the inoculated animals (0/20).  Not only did oral 
inoculation with IA3902 induce abortion, but our microscopic and immunohistochemical 
evaluations revealed suppurative placentitis, maternal vasculitis, and numerous organisms 
within subplacental trophoblasts and phagocytic cells, consistent with the microscopic 
appearance following experimental infection with C. jejuni in sheep.
11
  These results 
suggest that oral inoculation in pregnant guinea pigs will be a valuable model system for 
future investigations of pathogenesis, assessing virulence of field isolates, and 
development of therapeutic compounds and vaccines.   
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In the guinea pig, infection of subplacental trophoblasts with C. jejuni IA3902 is 
associated with increased expression of TLR2  
The innate immune system plays a key role in defense against pathogens at the 
maternofetal interface and the function of PRRs at this interface has been the subject of 
much recent research.
12
  TLRs are the most widely studied of the PRRs, and there have 
been several recent reports documenting alterations in their expression at the protein level 
in both pathologic and nonpathologic placentas;
13-16
 however, data regarding TLR 
responses to specific placental pathogens are limited.  In Chapter 3, we sought to 
determine if alterations in the expression of TLR2 or TLR4 would occur in subplacental 
trophoblasts from guinea pigs orally inoculated with C. jejuni IA3902.  In guinea pigs, 
the subplacental syncytiotrophoblast forms the frontal barrier between mother and fetus, 
and, as such, would be the first layer of the placenta exposed to potential pathogens 
arising from the endometrium, and, as maternal blood vessels enter the placental disc at 
the periphery of its junction with the subplacenta,
17
 the syncytiotrophoblast in this 
location would be the first exposed during episodes of bacteremia.  Using a combination 
of routine microscopy and immunohistochemistry on serial sections, we demonstrated 
significantly increased expression of TLR2 protein in syncytiotrophoblasts from 
placentas with suppurative placentitis and concurrent infection with C. jejuni; whereas 
immunoreactivity for TLR2 in syncytiotrophoblasts of inflamed but uninfected placentas 
and TLR4 expression in all infected or inflamed placentas was not significantly different 
versus sham-inoculated controls.  These results suggest that the presence of C. jejuni 
organisms was associated with the observed increase in TLR2 expression, and provide 
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support for future research to determine the exact role of TLR2 expression in the 
pathogenesis of Campylobacter-associated septic abortion.               
Commercially available, ovine-labeled Campylobacter vaccines are variably 
efficacious in preventing infection with C. jejuni IA3902 in guinea pigs 
While vaccination for the prevention of ovine campylobacteriosis was first 
described over 50 years ago,
18
 its usefulness is somewhat hindered by the heterogeneity 
of campylobacters associated with epizootics of abortion
19-23
 and the lack of cross 
protection between various serotypes, species and strains.
24-26
  Accordingly, we 
hypothesized that the emergence of a single clone of C. jejuni isolated from the 
preponderance of sheep abortions in the United States may be due to selective pressure 
imparted by resistance of this clone to traditional prevention strategies including 
vaccination.   
In Chapter 4, using a guinea pig model, we demonstrated that one of two 
commercially available, ovine-labeled multivalent Campylobacter vaccines was entirely 
ineffective in preventing systemic infection in intraperitoneally inoculated guinea pigs 48 
hours post inoculation, while a second commercially available vaccine was highly 
efficacious and comparable to a homologous bacterin in resolving infection in inoculated 
animals.  These results suggest that at least one commercially available vaccine may be 
ineffective in preventing disease due to IA3902 in sheep, and that a homologous bacterin 
may be an appropriate consideration in flocks experiencing disease.  Additionally, we 
demonstrated, for the first time, that resolution of infection in both pregnant and non-
pregnant guinea pigs 48 hours post inoculation was an effective tool for screening 
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vaccine efficacy.  As the use of non-pregnant animals provides a significant cost savings 
in early efficacy studies where large numbers of animals are required, these results 
provide the framework for an ideal model system that will be of significant benefit for 
future Campylobacter vaccine studies.   
The guinea pig placental unit contains components that drive chemotaxis and 
support growth of C. jejuni IA3902 
Previous studies have revealed that mucin and iron support the growth of C. 
jejuni
27,28
 and that the organism is driven by metabolism-dependent energy taxis toward 
optimal chemical conditions for growth.
29
  While C. jejuni has been traditionally deemed 
nonsaccharolytic, recent research has revealed that certain strains have the capacity to 
metabolize L-fucose.
30
  In Chapter 2, our immunohistochemical analysis of placentas 
from guinea pigs orally inoculated with IA3902 revealed numerous C. jejuni organisms 
within subplacental trophoblasts and phagocytic cells at the periphery of the junctional 
zone.  Given this consistent localization, we hypothesized that, in guinea pigs, the 
subplacenta and junctional zone contain factors which promote growth and drive taxis of 
C. jejuni IA3902 and that these factors are less prevalent or absent in other areas of the 
placenta.   
In Chapter 5, we demonstrated that two strains of C. jejuni, IA3902 and NCTC 
11168, grew more efficiently in subplacental tissue extracts than main placental extracts 
at 24 hours, and that only IA3902 maintained this enhanced growth in subplacental 
extracts at 48 hours.  We then used routine histochemistry and lectin histochemistry to 
characterize the spatial localization of acid and neutral mucins, iron, and L-fucose within 
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the guinea pig placental unit.  These analyses revealed that the subplacenta and junctional 
zone contained acid mucin, neutral mucin, and iron; whereas the main placenta contained 
only iron and scant amounts of acid mucin.  L-fucose containing surface glycans were 
only observed in the visceral yolk sac placenta.  Using select individual chemical factors 
in vitro we revealed that both strains of C. jejuni exhibited enhanced growth in the 
presence of mucin and iron at 24, 48, and 72 hours, and in the presence of L-fucose at 48 
and 72 hours.  Our in vitro chemotaxis studies revealed that both strains experience 
strong chemoattraction to L-fucose and chemorepulsion to bile regardless of pregnancy 
status.  In summary, these results support our hypothesis that the subplacenta and 
junctional zone contain factors that support the growth of C. jejuni, and that these factors 
are more prevalent in this location than in the main placenta.  Additionally, there is an 
abundance of a strongly chemoattractive and growth promoting substance in the visceral 
yolk sac placenta which may also play a role in the fetoplacental tropism we have 
observed with this organism.  The lack of an observable difference in behavior in the 
majority of our in vitro assays between a highly abortifacient strain (IA3902) and a strain 
previously demonstrated not to induce abortion following oral inoculation in pregnant 
guinea pigs (NCTC 11168; Chapter 2) suggests that energy taxis alone is not responsible 
for the observed differences in vivo, and should help focus future studies on other aspects 
of pathogenesis such as intestinal epithelial invasion, microbial gene expression, and 
evasion of the host immune response.   
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 Recommendations for Future Research 
These studies have revealed that oral inoculation of pregnant guinea pigs is an 
effective model for studying the pathogenesis of Campylobacter-associated septic 
abortion as it closely replicates the disease observed in sheep.  We have identified three 
strains of C. jejuni that exhibit markedly different pathogenicity in this model system and 
provide a framework for future pathogenesis studies.  There appear to be specific factors 
within the guinea pig placental unit that provide adequate resources for Campylobacter 
growth, and, while this helps to explain the effectiveness of C. jejuni as a placental 
pathogen in this species, it is not sufficient to explain our observed differences in overt 
disease caused by the various Campylobacter strains.  We observed intestinal 
colonization with all three species, thus it seems likely that the observed differences in 
pathogenicity lie early in the disease process and future studies aimed at these early steps 
seem warranted, such as differences in intestinal epithelial invasive capacity and the 
ability of different strains to evade the host immune response.  As Campylobacter spp., 
including C. jejuni, are often present in the gall bladder and intestines of apparently 
healthy sheep,
31,32
 differences in microbial gene expression may also underlay differences 
in pathogenic behavior and may be an important area of future study.   
Our studies also revealed that, similar to observations in sheep,
31-35
 pathogenic 
campylobacters readily colonize the guinea pig gall bladder and are recoverable from the 
bile.  Gall bladder colonization and intermittent shedding may be a key event in the 
epidemiology of disease within infected flocks,
33
 and studies determining the spatial 
localization of organisms within the gall bladder epithelium and mucus layer as well as 
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those involving microbial gene expression in the presence of bile from both pregnant and 
non-pregnant animals would be of value in elucidating the behavior of these organisms 
within the bile and the role of this colonization in the overall pathogenesis of ovine 
campylobacteriosis.  
While we observed increased expression of TLR2 protein in subplacental 
syncytiotrophoblasts from guinea pigs infected with IA3902, the exact role of this 
expression in the overall pathogenesis of Campylobacter-associated septic abortion 
remains to be determined.  Further study involving the quantification of inflammatory 
cytokine responses, such as IL-6, IL-8 and TNF-α, in fetal fluids and placental tissues 
from guinea pigs infected with IA3902, as well as quantification of apoptosis in placental 
trophoblasts, may give additional information regarding the potential role of TLRs in this 
disease.  Additionally, comparing these effects to those occurring in response to the 
administration of exogenous TLR2 and TLR4 agonists, TLR2 and TLR4 antagonists, and 
infection with IA3902 in TLR knock out animals would all be of value in further 
delineating the potential role of these receptors in the pathogenesis of adverse pregnancy 
outcomes secondary to sepsis with C. jejuni.   
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